Gene Symbol | Gene ID | Gene Info |
---|---|---|
Snai1
|
ENSMUSG00000042821.7 | snail family zinc finger 1 |
Zeb1
|
ENSMUSG00000024238.7 | zinc finger E-box binding homeobox 1 |
Snai2
|
ENSMUSG00000022676.6 | snail family zinc finger 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_167537335_167537499 | Snai1 | 778 | 0.481081 | 0.43 | 1.1e-03 | Click! |
chr2_167537559_167538716 | Snai1 | 58 | 0.954755 | 0.13 | 3.6e-01 | Click! |
chr2_167544496_167544708 | Snai1 | 6407 | 0.123339 | 0.08 | 5.5e-01 | Click! |
chr2_167543102_167543266 | Snai1 | 4989 | 0.130918 | -0.07 | 6.0e-01 | Click! |
chr2_167540272_167540507 | Snai1 | 2194 | 0.197022 | 0.07 | 6.4e-01 | Click! |
chr16_14705731_14705948 | Snai2 | 13 | 0.984589 | -0.34 | 1.0e-02 | Click! |
chr16_14706197_14706361 | Snai2 | 427 | 0.880275 | -0.30 | 2.8e-02 | Click! |
chr16_14705231_14705600 | Snai2 | 437 | 0.876185 | -0.29 | 3.3e-02 | Click! |
chr16_14712371_14712532 | Snai2 | 6599 | 0.256799 | -0.25 | 6.7e-02 | Click! |
chr16_14705955_14706173 | Snai2 | 212 | 0.955911 | -0.22 | 1.1e-01 | Click! |
chr18_5593090_5593338 | Zeb1 | 94 | 0.739697 | -0.40 | 2.4e-03 | Click! |
chr18_5603185_5603788 | Zeb1 | 258 | 0.879537 | -0.39 | 2.9e-03 | Click! |
chr18_5820293_5820607 | Zeb1 | 89369 | 0.082722 | -0.32 | 1.6e-02 | Click! |
chr18_5835159_5835564 | Zeb1 | 104280 | 0.065422 | -0.30 | 2.6e-02 | Click! |
chr18_5603896_5604174 | Zeb1 | 291 | 0.859036 | -0.30 | 2.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_153492229_153493481 | 57.36 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chrX_123721926_123722462 | 36.55 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr19_16435353_16436213 | 35.47 |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
21 |
0.98 |
chrX_123500550_123501093 | 35.25 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chrX_123271195_123271712 | 34.74 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chrX_123943434_123943951 | 34.70 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr19_55595965_55596129 | 34.47 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
145773 |
0.04 |
chr9_109094576_109096217 | 33.82 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr3_100488535_100489982 | 33.10 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr1_74900735_74901342 | 32.70 |
Mir375 |
microRNA 375 |
317 |
0.76 |
chr18_82474598_82476191 | 32.64 |
Mbp |
myelin basic protein |
24 |
0.98 |
chr2_118662761_118664171 | 32.54 |
Pak6 |
p21 (RAC1) activated kinase 6 |
163 |
0.94 |
chr2_173032812_173033942 | 32.24 |
Gm14453 |
predicted gene 14453 |
1203 |
0.38 |
chr12_25092319_25093283 | 31.60 |
Id2 |
inhibitor of DNA binding 2 |
3286 |
0.21 |
chr10_77130088_77130939 | 29.15 |
Gm7775 |
predicted gene 7775 |
6587 |
0.19 |
chr14_48475621_48476075 | 28.59 |
Tmem260 |
transmembrane protein 260 |
3526 |
0.2 |
chr4_107366540_107366691 | 28.59 |
Ndc1 |
NDC1 transmembrane nucleoporin |
1169 |
0.38 |
chr11_69965261_69965757 | 28.49 |
Cldn7 |
claudin 7 |
113 |
0.88 |
chr2_66124084_66125291 | 27.97 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
307 |
0.72 |
chr12_73546456_73546654 | 27.76 |
Tmem30b |
transmembrane protein 30B |
163 |
0.93 |
chr5_139813953_139814437 | 27.27 |
Tmem184a |
transmembrane protein 184a |
88 |
0.95 |
chr19_53080891_53081464 | 26.72 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr3_89390311_89391266 | 26.66 |
Gm15417 |
predicted gene 15417 |
1062 |
0.22 |
chr8_83584955_83585106 | 26.13 |
Gm45823 |
predicted gene 45823 |
495 |
0.63 |
chr11_100938783_100940230 | 25.72 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr2_72866399_72866579 | 25.38 |
6430710C18Rik |
RIKEN cDNA 6430710C18 gene |
52772 |
0.11 |
chr7_19800187_19800338 | 25.29 |
Cblc |
Casitas B-lineage lymphoma c |
3453 |
0.09 |
chr4_152160777_152161086 | 24.84 |
Hes2 |
hes family bHLH transcription factor 2 |
1382 |
0.28 |
chr2_25080372_25080586 | 24.59 |
Entpd8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
30 |
0.94 |
chr4_156055284_156055465 | 24.43 |
Mir200b |
microRNA 200b |
376 |
0.4 |
chr1_157525893_157526398 | 23.99 |
Sec16b |
SEC16 homolog B (S. cerevisiae) |
2 |
0.97 |
chr15_102016590_102017449 | 23.82 |
Krt18 |
keratin 18 |
11161 |
0.11 |
chr1_193153262_193153458 | 23.80 |
Irf6 |
interferon regulatory factor 6 |
206 |
0.9 |
chr16_4549405_4549570 | 23.77 |
Tfap4 |
transcription factor AP4 |
3475 |
0.17 |
chr17_84181102_84182153 | 23.70 |
Gm36279 |
predicted gene, 36279 |
4129 |
0.18 |
chr9_77046149_77046318 | 23.45 |
Tinag |
tubulointerstitial nephritis antigen |
439 |
0.47 |
chr2_168023853_168024004 | 23.40 |
Ripor3 |
RIPOR family member 3 |
13310 |
0.14 |
chr4_118543957_118544344 | 23.22 |
Tmem125 |
transmembrane protein 125 |
106 |
0.94 |
chr16_76358221_76358461 | 23.08 |
Nrip1 |
nuclear receptor interacting protein 1 |
14696 |
0.2 |
chr8_122317511_122318419 | 23.06 |
Zfpm1 |
zinc finger protein, multitype 1 |
10645 |
0.13 |
chr10_119010890_119011286 | 22.88 |
Gm47461 |
predicted gene, 47461 |
10582 |
0.17 |
chr4_154914768_154915113 | 22.80 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
13137 |
0.11 |
chr2_128359325_128359478 | 22.64 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
25533 |
0.19 |
chr8_123736966_123737350 | 22.50 |
Gm45781 |
predicted gene 45781 |
2016 |
0.14 |
chr11_102218354_102219649 | 22.44 |
Hdac5 |
histone deacetylase 5 |
72 |
0.94 |
chr6_124718799_124718986 | 22.27 |
Gm15884 |
predicted gene 15884 |
61 |
0.79 |
chr4_118527131_118527346 | 22.23 |
2610528J11Rik |
RIKEN cDNA 2610528J11 gene |
5 |
0.96 |
chr16_30050922_30051094 | 21.63 |
9030404E10Rik |
RIKEN cDNA 9030404E10 gene |
11529 |
0.15 |
chr9_121415591_121416113 | 21.63 |
Trak1 |
trafficking protein, kinesin binding 1 |
123 |
0.97 |
chr4_133518859_133519071 | 21.27 |
Kdf1 |
keratinocyte differentiation factor 1 |
2 |
0.96 |
chr9_110653586_110654769 | 21.23 |
Nbeal2 |
neurobeachin-like 2 |
16 |
0.94 |
chr17_15588225_15588395 | 21.19 |
Gm3507 |
predicted gene 3507 |
9618 |
0.11 |
chr12_103956494_103956864 | 21.08 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
219 |
0.88 |
chr12_111437603_111437970 | 20.91 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
4683 |
0.13 |
chr4_11147564_11147752 | 20.77 |
Gm11830 |
predicted gene 11830 |
2948 |
0.16 |
chr16_55816273_55816463 | 20.75 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
2147 |
0.3 |
chr5_139317377_139317773 | 20.56 |
Adap1 |
ArfGAP with dual PH domains 1 |
8047 |
0.13 |
chr12_76558245_76558525 | 20.48 |
Plekhg3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
3853 |
0.17 |
chr13_59795759_59796072 | 20.34 |
Tut7 |
terminal uridylyl transferase 7 |
1215 |
0.28 |
chr8_94974142_94974748 | 20.29 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
306 |
0.84 |
chr4_148947936_148948318 | 20.28 |
Gm13205 |
predicted gene 13205 |
787 |
0.46 |
chr7_19800658_19801013 | 20.22 |
Cblc |
Casitas B-lineage lymphoma c |
4026 |
0.09 |
chr4_156077703_156078324 | 20.21 |
Gm13648 |
predicted gene 13648 |
18211 |
0.07 |
chr19_34074450_34074610 | 20.13 |
Gm23334 |
predicted gene, 23334 |
5599 |
0.15 |
chr18_75297242_75297593 | 20.12 |
2010010A06Rik |
RIKEN cDNA 2010010A06 gene |
88 |
0.98 |
chr5_31968046_31968274 | 20.02 |
Gm43811 |
predicted gene 43811 |
41463 |
0.14 |
chr10_81095272_81095757 | 20.01 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
2939 |
0.1 |
chr8_104374837_104375423 | 19.93 |
Gm45877 |
predicted gene 45877 |
11462 |
0.09 |
chr9_45203971_45204289 | 19.88 |
Tmprss4 |
transmembrane protease, serine 4 |
38 |
0.95 |
chr11_96929113_96929565 | 19.84 |
Prr15l |
proline rich 15-like |
15 |
0.95 |
chr6_86765617_86765810 | 19.78 |
Anxa4 |
annexin A4 |
94 |
0.96 |
chr14_119006528_119007145 | 19.71 |
Uggt2 |
UDP-glucose glycoprotein glucosyltransferase 2 |
119 |
0.97 |
chr8_106603148_106603490 | 19.52 |
Cdh1 |
cadherin 1 |
32 |
0.97 |
chr2_69818805_69818994 | 19.50 |
Klhl23 |
kelch-like 23 |
3045 |
0.15 |
chr3_60057433_60057585 | 19.48 |
Sucnr1 |
succinate receptor 1 |
24360 |
0.14 |
chr11_87763473_87764852 | 19.47 |
Tspoap1 |
TSPO associated protein 1 |
569 |
0.56 |
chr10_81128365_81128844 | 19.46 |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
11 |
0.94 |
chr7_122152629_122152946 | 19.42 |
Gm15489 |
predicted gene 15489 |
6614 |
0.09 |
chr12_3781008_3781794 | 19.37 |
Dtnb |
dystrobrevin, beta |
1853 |
0.32 |
chr12_105000459_105000765 | 19.32 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
1935 |
0.22 |
chr19_5553843_5554168 | 19.31 |
Ovol1 |
ovo like zinc finger 1 |
5398 |
0.08 |
chr17_28769114_28769410 | 19.28 |
Mapk13 |
mitogen-activated protein kinase 13 |
35 |
0.96 |
chr5_73189889_73190209 | 19.19 |
Gm42571 |
predicted gene 42571 |
368 |
0.78 |
chr1_135248355_135248854 | 19.17 |
Gm26642 |
predicted gene, 26642 |
43 |
0.96 |
chr4_132075006_132075723 | 19.10 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr8_122421630_122421919 | 19.09 |
Il17c |
interleukin 17C |
246 |
0.83 |
chr4_156059768_156060161 | 19.07 |
Gm13648 |
predicted gene 13648 |
162 |
0.77 |
chr10_127657764_127657946 | 19.06 |
Stat6 |
signal transducer and activator of transcription 6 |
1094 |
0.28 |
chr17_24948381_24948532 | 18.98 |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
11479 |
0.1 |
chr10_93666253_93666601 | 18.94 |
Gm8580 |
predicted gene 8580 |
581 |
0.67 |
chr2_32471096_32471276 | 18.93 |
Gm37169 |
predicted gene, 37169 |
16802 |
0.09 |
chr9_98467076_98467241 | 18.93 |
Rbp2 |
retinol binding protein 2, cellular |
18957 |
0.16 |
chr19_43813321_43813649 | 18.84 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
2963 |
0.21 |
chr15_41788849_41789548 | 18.82 |
Oxr1 |
oxidation resistance 1 |
183 |
0.64 |
chr12_105000187_105000371 | 18.79 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
1602 |
0.26 |
chr11_35964231_35964594 | 18.77 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
16115 |
0.21 |
chr4_134081752_134082448 | 18.68 |
Crybg2 |
crystallin beta-gamma domain containing 2 |
212 |
0.88 |
chr15_36899223_36899602 | 18.67 |
Gm10384 |
predicted gene 10384 |
19596 |
0.14 |
chr5_138875878_138876033 | 18.67 |
Gm5294 |
predicted gene 5294 |
55875 |
0.11 |
chr7_28834225_28834652 | 18.63 |
Lgals4 |
lectin, galactose binding, soluble 4 |
85 |
0.93 |
chr7_25430237_25430677 | 18.61 |
Gm20949 |
predicted gene, 20949 |
7665 |
0.1 |
chr5_28563015_28563209 | 18.60 |
Gm43161 |
predicted gene 43161 |
14161 |
0.21 |
chr15_36688365_36688735 | 18.54 |
Gm10385 |
predicted gene 10385 |
1553 |
0.31 |
chr4_10924249_10924462 | 18.44 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
22253 |
0.14 |
chr19_6007132_6007287 | 18.42 |
Gm10814 |
predicted gene 10814 |
5411 |
0.07 |
chr1_167374719_167374895 | 18.32 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
10641 |
0.13 |
chr2_172906015_172906191 | 18.31 |
Bmp7 |
bone morphogenetic protein 7 |
33989 |
0.15 |
chr16_43979232_43980076 | 18.28 |
Zdhhc23 |
zinc finger, DHHC domain containing 23 |
137 |
0.95 |
chr7_31115171_31115481 | 18.28 |
Hpn |
hepsin |
36 |
0.95 |
chr3_94693305_94693640 | 18.26 |
Selenbp2 |
selenium binding protein 2 |
84 |
0.95 |
chr10_127657981_127658224 | 18.24 |
Stat6 |
signal transducer and activator of transcription 6 |
1298 |
0.23 |
chr1_64787973_64788169 | 18.23 |
Plekhm3 |
pleckstrin homology domain containing, family M, member 3 |
48693 |
0.1 |
chr15_73117919_73118528 | 18.21 |
Ago2 |
argonaute RISC catalytic subunit 2 |
4169 |
0.24 |
chr13_100552408_100552870 | 18.14 |
Ocln |
occludin |
16 |
0.96 |
chr18_62191193_62191482 | 18.13 |
Gm9949 |
predicted gene 9949 |
11211 |
0.2 |
chr11_115450207_115450517 | 18.09 |
Mir3968 |
microRNA 3968 |
2302 |
0.12 |
chr9_21312247_21312534 | 18.03 |
Ap1m2 |
adaptor protein complex AP-1, mu 2 subunit |
53 |
0.94 |
chr2_163541937_163542094 | 18.02 |
Hnf4aos |
hepatic nuclear factor 4 alpha, opposite strand |
295 |
0.85 |
chr7_145092515_145092693 | 18.01 |
Gm45181 |
predicted gene 45181 |
70392 |
0.1 |
chr4_150572240_150572391 | 18.01 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
2658 |
0.27 |
chr7_44683455_44684071 | 18.00 |
2310016G11Rik |
RIKEN cDNA 2310016G11 gene |
6909 |
0.1 |
chr2_93455084_93455235 | 18.00 |
Gm10804 |
predicted gene 10804 |
2338 |
0.24 |
chr1_151131383_151131556 | 17.88 |
Gm8941 |
predicted gene 8941 |
5038 |
0.14 |
chr2_38647265_38647733 | 17.72 |
Psmb7 |
proteasome (prosome, macropain) subunit, beta type 7 |
3412 |
0.15 |
chr5_108692059_108693005 | 17.66 |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
150 |
0.92 |
chr7_45720839_45721253 | 17.59 |
Fam83e |
family with sequence similarity 83, member E |
166 |
0.8 |
chr5_135001339_135001605 | 17.57 |
Wbscr25 |
Williams Beuren syndrome chromosome region 25 (human) |
122 |
0.9 |
chr11_115872435_115872990 | 17.57 |
Myo15b |
myosin XVB |
4804 |
0.11 |
chr4_154025644_154026533 | 17.56 |
Smim1 |
small integral membrane protein 1 |
51 |
0.95 |
chr7_141079609_141079883 | 17.53 |
Pkp3 |
plakophilin 3 |
14 |
0.94 |
chr15_66980338_66980727 | 17.53 |
Ndrg1 |
N-myc downstream regulated gene 1 |
10892 |
0.17 |
chr8_109962118_109962299 | 17.47 |
Marveld3 |
MARVEL (membrane-associating) domain containing 3 |
5 |
0.97 |
chr11_86580429_86580773 | 17.46 |
Mir21a |
microRNA 21a |
3557 |
0.18 |
chr11_72582128_72582279 | 17.46 |
Gm12712 |
predicted gene 12712 |
8873 |
0.14 |
chr6_125380218_125380671 | 17.44 |
Plekhg6 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
349 |
0.83 |
chrX_7739481_7739648 | 17.36 |
Ccdc120 |
coiled-coil domain containing 120 |
643 |
0.46 |
chr2_6162543_6162701 | 17.33 |
Gm13384 |
predicted gene 13384 |
28666 |
0.12 |
chr8_111393298_111394128 | 17.32 |
Fa2h |
fatty acid 2-hydroxylase |
105 |
0.96 |
chr1_132586898_132587185 | 17.29 |
Nfasc |
neurofascin |
99 |
0.97 |
chr13_104029221_104029379 | 17.29 |
Nln |
neurolysin (metallopeptidase M3 family) |
5273 |
0.23 |
chr13_4606879_4607177 | 17.29 |
Akr1e1 |
aldo-keto reductase family 1, member E1 |
2090 |
0.25 |
chr10_79822356_79822726 | 17.26 |
Misp |
mitotic spindle positioning |
17 |
0.93 |
chr4_148902862_148903422 | 17.24 |
Casz1 |
castor zinc finger 1 |
1993 |
0.3 |
chr11_103340154_103340451 | 17.18 |
Arhgap27 |
Rho GTPase activating protein 27 |
583 |
0.64 |
chr8_22434254_22434804 | 17.18 |
Mrps31 |
mitochondrial ribosomal protein S31 |
23131 |
0.09 |
chr14_14347096_14348750 | 17.12 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr5_119070049_119070379 | 17.12 |
1700081H04Rik |
RIKEN cDNA 1700081H04 gene |
38020 |
0.17 |
chr11_115462239_115462679 | 16.92 |
Slc16a5 |
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
15 |
0.92 |
chr1_88408427_88408581 | 16.85 |
Spp2 |
secreted phosphoprotein 2 |
1098 |
0.47 |
chr7_29281838_29282175 | 16.82 |
Spint2 |
serine protease inhibitor, Kunitz type 2 |
94 |
0.94 |
chr5_47982936_47984535 | 16.80 |
Slit2 |
slit guidance ligand 2 |
558 |
0.73 |
chr5_124091870_124092203 | 16.78 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
1774 |
0.21 |
chr6_122591150_122591312 | 16.73 |
Apobec1 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
8896 |
0.1 |
chr5_43948006_43948538 | 16.72 |
Gm43183 |
predicted gene 43183 |
156 |
0.73 |
chr4_136842779_136843098 | 16.67 |
Ephb2 |
Eph receptor B2 |
6950 |
0.19 |
chr10_80160842_80161483 | 16.66 |
Cirbp |
cold inducible RNA binding protein |
4823 |
0.09 |
chr7_131256975_131257257 | 16.65 |
Cdcp3 |
CUB domain containing protein 3 |
46863 |
0.09 |
chr9_15245406_15245599 | 16.62 |
Vstm5 |
V-set and transmembrane domain containing 5 |
6457 |
0.09 |
chr16_87602527_87602990 | 16.59 |
Gm22808 |
predicted gene, 22808 |
18362 |
0.17 |
chr4_11386541_11386917 | 16.59 |
Esrp1 |
epithelial splicing regulatory protein 1 |
50 |
0.97 |
chr10_80150235_80151164 | 16.54 |
Midn |
midnolin |
242 |
0.82 |
chr11_69858633_69858963 | 16.51 |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
68 |
0.9 |
chr10_54073848_54074262 | 16.43 |
Man1a |
mannosidase 1, alpha |
1654 |
0.31 |
chr19_42722452_42722956 | 16.37 |
Gm25216 |
predicted gene, 25216 |
22802 |
0.13 |
chr4_62517204_62517445 | 16.36 |
Alad |
aminolevulinate, delta-, dehydratase |
2557 |
0.17 |
chr8_94977210_94977404 | 16.36 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
198 |
0.91 |
chr12_104863654_104864042 | 16.35 |
Clmn |
calmin |
1161 |
0.39 |
chr7_110792851_110793160 | 16.31 |
Rnf141 |
ring finger protein 141 |
8594 |
0.14 |
chr4_144893602_144894367 | 16.30 |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
765 |
0.69 |
chr12_103827736_103827948 | 16.30 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
2531 |
0.15 |
chr6_30173848_30174358 | 16.27 |
Rncr4 |
retina expressed non-coding RNA 4 |
1210 |
0.35 |
chr8_94186589_94186942 | 16.19 |
Gm39228 |
predicted gene, 39228 |
3476 |
0.12 |
chr5_64623783_64623974 | 16.17 |
Gm42565 |
predicted gene 42565 |
11962 |
0.12 |
chr4_108233759_108233910 | 16.15 |
Zyg11b |
zyg-ll family member B, cell cycle regulator |
8204 |
0.16 |
chr17_23660414_23660652 | 16.15 |
Bicdl2 |
BICD family like cargo adaptor 2 |
27 |
0.92 |
chr18_65025526_65026378 | 16.11 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
150 |
0.97 |
chr2_25234578_25234737 | 16.06 |
Slc34a3 |
solute carrier family 34 (sodium phosphate), member 3 |
293 |
0.67 |
chr11_43174858_43175188 | 16.06 |
Atp10b |
ATPase, class V, type 10B |
19352 |
0.19 |
chr9_44417474_44417945 | 16.05 |
Ccdc84 |
coiled-coil domain containing 84 |
277 |
0.71 |
chr11_75206447_75206598 | 15.99 |
Rtn4rl1 |
reticulon 4 receptor-like 1 |
12739 |
0.1 |
chr10_128579441_128579708 | 15.96 |
Mir6917 |
microRNA 6917 |
4923 |
0.07 |
chr15_76697423_76698657 | 15.95 |
Gpt |
glutamic pyruvic transaminase, soluble |
22 |
0.93 |
chr1_133882372_133883076 | 15.95 |
Optc |
opticin |
18603 |
0.12 |
chr4_154299785_154300430 | 15.94 |
Arhgef16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
53 |
0.97 |
chr8_128425020_128425224 | 15.92 |
Nrp1 |
neuropilin 1 |
65725 |
0.12 |
chr4_119028467_119028820 | 15.90 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr4_154021521_154021945 | 15.87 |
Lrrc47 |
leucine rich repeat containing 47 |
2094 |
0.17 |
chr1_89026213_89026430 | 15.86 |
1700067G17Rik |
RIKEN cDNA 1700067G17 gene |
10208 |
0.18 |
chr15_76816855_76818442 | 15.86 |
Arhgap39 |
Rho GTPase activating protein 39 |
322 |
0.82 |
chr8_117718550_117718744 | 15.82 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
2289 |
0.22 |
chr7_141361612_141361824 | 15.81 |
Eps8l2 |
EPS8-like 2 |
181 |
0.86 |
chr2_132945269_132945933 | 15.77 |
Fermt1 |
fermitin family member 1 |
28 |
0.97 |
chr7_44668477_44668662 | 15.76 |
2310016G11Rik |
RIKEN cDNA 2310016G11 gene |
336 |
0.66 |
chr13_76055426_76056750 | 15.75 |
Gpr150 |
G protein-coupled receptor 150 |
908 |
0.49 |
chr15_80760942_80761256 | 15.73 |
Tnrc6b |
trinucleotide repeat containing 6b |
37543 |
0.13 |
chr6_119479409_119481030 | 15.72 |
Fbxl14 |
F-box and leucine-rich repeat protein 14 |
551 |
0.78 |
chr10_80576603_80578409 | 15.72 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr3_145634135_145634315 | 15.68 |
Ccn1 |
cellular communication network factor 1 |
15756 |
0.17 |
chr8_123708869_123709041 | 15.66 |
6030466F02Rik |
RIKEN cDNA 6030466F02 gene |
25003 |
0.06 |
chr11_105943755_105944600 | 15.66 |
Cyb561 |
cytochrome b-561 |
38 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.2 | 51.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
14.7 | 14.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
12.5 | 37.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
12.0 | 35.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
11.9 | 35.8 | GO:1902896 | terminal web assembly(GO:1902896) |
11.4 | 34.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
11.3 | 11.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
11.0 | 32.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
10.2 | 30.7 | GO:0032439 | endosome localization(GO:0032439) |
10.0 | 29.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
9.5 | 28.6 | GO:0002432 | granuloma formation(GO:0002432) |
9.4 | 37.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
9.3 | 37.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
9.2 | 27.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
9.2 | 27.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
9.0 | 54.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
9.0 | 27.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
8.5 | 16.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
8.3 | 33.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
8.3 | 41.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
8.2 | 24.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
8.1 | 32.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
8.1 | 16.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
8.1 | 24.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
8.1 | 24.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
7.7 | 23.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
7.7 | 23.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
7.6 | 22.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
7.6 | 22.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
7.6 | 22.7 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
7.4 | 44.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
7.2 | 21.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
7.1 | 28.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
7.1 | 28.2 | GO:1904673 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
7.0 | 28.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
7.0 | 34.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
7.0 | 20.9 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
7.0 | 20.9 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
6.9 | 27.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
6.9 | 27.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
6.9 | 20.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
6.8 | 20.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
6.8 | 27.2 | GO:0070295 | renal water absorption(GO:0070295) |
6.8 | 27.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
6.7 | 13.5 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
6.7 | 33.7 | GO:0019532 | oxalate transport(GO:0019532) |
6.6 | 6.6 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
6.5 | 19.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
6.5 | 19.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
6.5 | 38.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
6.4 | 32.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
6.4 | 19.2 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
6.3 | 62.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
6.2 | 24.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
6.2 | 12.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
6.1 | 18.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
6.1 | 12.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
6.0 | 6.0 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
5.9 | 17.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
5.9 | 29.6 | GO:1904970 | brush border assembly(GO:1904970) |
5.9 | 11.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
5.9 | 29.5 | GO:0070627 | ferrous iron import(GO:0070627) |
5.8 | 17.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
5.8 | 34.7 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
5.8 | 34.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
5.7 | 17.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
5.7 | 34.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
5.7 | 17.0 | GO:0008050 | female courtship behavior(GO:0008050) |
5.6 | 11.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
5.6 | 16.8 | GO:0000087 | mitotic M phase(GO:0000087) |
5.5 | 11.1 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
5.5 | 21.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
5.5 | 10.9 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
5.5 | 5.5 | GO:0036166 | phenotypic switching(GO:0036166) |
5.5 | 10.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
5.4 | 16.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
5.4 | 21.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
5.4 | 5.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
5.4 | 16.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
5.3 | 5.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
5.3 | 21.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
5.3 | 10.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
5.3 | 26.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
5.2 | 10.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
5.1 | 5.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
5.1 | 15.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
5.1 | 15.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
5.1 | 56.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
5.1 | 15.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
5.1 | 15.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
5.1 | 20.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
5.0 | 20.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
5.0 | 15.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
5.0 | 24.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
5.0 | 19.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
4.9 | 9.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
4.9 | 14.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
4.9 | 29.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
4.9 | 19.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
4.9 | 14.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
4.9 | 9.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
4.9 | 19.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
4.8 | 14.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
4.8 | 24.2 | GO:0051639 | actin filament network formation(GO:0051639) |
4.8 | 9.6 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
4.8 | 14.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
4.8 | 4.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
4.8 | 4.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
4.8 | 19.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
4.8 | 23.9 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
4.7 | 14.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
4.7 | 14.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
4.7 | 9.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
4.7 | 4.7 | GO:1901992 | positive regulation of mitotic cell cycle(GO:0045931) positive regulation of mitotic cell cycle phase transition(GO:1901992) |
4.6 | 13.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
4.6 | 9.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
4.6 | 46.3 | GO:0034063 | stress granule assembly(GO:0034063) |
4.6 | 4.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
4.6 | 9.2 | GO:0016264 | gap junction assembly(GO:0016264) |
4.6 | 13.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
4.6 | 32.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
4.6 | 9.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
4.5 | 4.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
4.5 | 4.5 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
4.5 | 4.5 | GO:0007031 | peroxisome organization(GO:0007031) |
4.5 | 4.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
4.5 | 35.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
4.5 | 8.9 | GO:0002159 | desmosome assembly(GO:0002159) |
4.5 | 8.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
4.5 | 13.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
4.4 | 13.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
4.4 | 22.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
4.4 | 13.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
4.4 | 13.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
4.4 | 26.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
4.4 | 13.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.4 | 43.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
4.4 | 26.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
4.3 | 17.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
4.3 | 12.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
4.3 | 8.6 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
4.3 | 17.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
4.3 | 25.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
4.3 | 8.5 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
4.2 | 12.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
4.2 | 8.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
4.2 | 4.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
4.2 | 12.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.2 | 25.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
4.2 | 37.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
4.2 | 29.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
4.1 | 8.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
4.1 | 8.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
4.1 | 16.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
4.1 | 12.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
4.1 | 4.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
4.1 | 12.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
4.1 | 12.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
4.1 | 16.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
4.1 | 8.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
4.0 | 4.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
4.0 | 20.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
4.0 | 40.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
4.0 | 8.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
4.0 | 32.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
4.0 | 4.0 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
4.0 | 4.0 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
4.0 | 12.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
4.0 | 19.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
4.0 | 15.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
4.0 | 19.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
3.9 | 11.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
3.9 | 11.8 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
3.9 | 15.7 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
3.9 | 3.9 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
3.9 | 15.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
3.9 | 23.4 | GO:0042737 | drug catabolic process(GO:0042737) |
3.9 | 46.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
3.9 | 11.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
3.9 | 31.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
3.9 | 11.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.9 | 11.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
3.9 | 3.9 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
3.9 | 27.1 | GO:0015825 | L-serine transport(GO:0015825) |
3.8 | 19.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
3.8 | 23.0 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
3.8 | 26.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
3.8 | 26.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.8 | 3.8 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
3.8 | 15.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
3.8 | 7.6 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
3.8 | 15.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
3.8 | 30.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.8 | 7.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
3.8 | 7.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.8 | 22.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
3.8 | 15.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
3.8 | 7.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
3.8 | 11.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
3.8 | 93.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
3.7 | 11.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
3.7 | 3.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
3.7 | 11.2 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
3.7 | 11.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
3.7 | 3.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
3.7 | 3.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
3.7 | 3.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
3.7 | 11.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
3.7 | 29.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
3.7 | 7.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
3.7 | 11.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.7 | 3.7 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
3.7 | 18.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
3.7 | 29.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
3.6 | 10.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
3.6 | 10.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
3.6 | 18.2 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
3.6 | 3.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
3.6 | 10.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
3.6 | 32.6 | GO:0060539 | diaphragm development(GO:0060539) |
3.6 | 21.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
3.6 | 25.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
3.6 | 7.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
3.6 | 10.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
3.6 | 14.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
3.6 | 14.3 | GO:0006116 | NADH oxidation(GO:0006116) |
3.6 | 7.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
3.6 | 10.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
3.6 | 17.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
3.6 | 17.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
3.6 | 14.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.5 | 14.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
3.5 | 17.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
3.5 | 14.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.5 | 7.0 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
3.5 | 17.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
3.5 | 3.5 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
3.5 | 10.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
3.5 | 7.0 | GO:0015684 | ferrous iron transport(GO:0015684) |
3.5 | 7.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
3.5 | 10.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.5 | 13.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
3.5 | 34.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
3.5 | 3.5 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
3.4 | 6.9 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
3.4 | 13.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.4 | 27.0 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
3.4 | 10.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
3.4 | 10.1 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
3.4 | 13.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
3.4 | 30.2 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
3.4 | 6.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
3.3 | 3.3 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
3.3 | 13.3 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.3 | 33.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
3.3 | 13.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
3.3 | 16.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
3.3 | 3.3 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
3.3 | 6.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
3.3 | 32.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
3.3 | 9.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
3.3 | 9.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.3 | 19.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
3.3 | 9.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
3.3 | 29.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
3.3 | 3.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
3.2 | 3.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
3.2 | 55.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
3.2 | 35.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
3.2 | 6.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
3.2 | 6.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.2 | 9.6 | GO:0072553 | terminal button organization(GO:0072553) |
3.2 | 19.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
3.2 | 9.6 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
3.2 | 22.4 | GO:0032782 | bile acid secretion(GO:0032782) |
3.2 | 6.4 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
3.2 | 9.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.2 | 6.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
3.2 | 6.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
3.2 | 15.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
3.2 | 28.4 | GO:0010226 | response to lithium ion(GO:0010226) |
3.1 | 3.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
3.1 | 34.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
3.1 | 9.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.1 | 12.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.1 | 9.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
3.1 | 3.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
3.1 | 12.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
3.1 | 12.4 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
3.1 | 15.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
3.1 | 15.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
3.1 | 3.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
3.1 | 3.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
3.1 | 12.2 | GO:0060157 | urinary bladder development(GO:0060157) |
3.1 | 21.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
3.0 | 6.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
3.0 | 39.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
3.0 | 21.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
3.0 | 18.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
3.0 | 12.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
3.0 | 3.0 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
3.0 | 9.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.0 | 8.9 | GO:0008228 | opsonization(GO:0008228) |
3.0 | 14.8 | GO:0071321 | cellular response to cGMP(GO:0071321) |
3.0 | 5.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
3.0 | 23.7 | GO:0006525 | arginine metabolic process(GO:0006525) |
3.0 | 5.9 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.9 | 8.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.9 | 8.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
2.9 | 11.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.9 | 8.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.9 | 11.7 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
2.9 | 8.7 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.9 | 2.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
2.9 | 14.6 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
2.9 | 2.9 | GO:0032347 | regulation of aldosterone biosynthetic process(GO:0032347) |
2.9 | 5.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.9 | 40.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
2.9 | 2.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.9 | 5.8 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
2.9 | 8.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.9 | 2.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.9 | 2.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.9 | 28.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
2.9 | 20.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.9 | 11.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.9 | 2.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
2.8 | 8.5 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
2.8 | 11.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
2.8 | 8.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
2.8 | 48.2 | GO:0050779 | RNA destabilization(GO:0050779) |
2.8 | 11.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.8 | 42.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
2.8 | 28.1 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) |
2.8 | 5.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.8 | 39.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
2.8 | 11.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
2.8 | 11.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
2.8 | 11.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.8 | 22.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
2.8 | 11.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.8 | 11.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
2.7 | 11.0 | GO:0015871 | choline transport(GO:0015871) |
2.7 | 11.0 | GO:0018343 | protein farnesylation(GO:0018343) |
2.7 | 8.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
2.7 | 19.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
2.7 | 5.5 | GO:0048102 | autophagic cell death(GO:0048102) |
2.7 | 13.7 | GO:0018101 | protein citrullination(GO:0018101) |
2.7 | 32.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
2.7 | 5.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
2.7 | 10.8 | GO:0003091 | renal water homeostasis(GO:0003091) |
2.7 | 13.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
2.7 | 5.4 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
2.7 | 10.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.7 | 18.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.7 | 8.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
2.7 | 21.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.7 | 18.6 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
2.7 | 10.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
2.6 | 7.9 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.6 | 37.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
2.6 | 18.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.6 | 2.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.6 | 7.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.6 | 15.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
2.6 | 42.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.6 | 5.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
2.6 | 13.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
2.6 | 10.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
2.6 | 28.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
2.6 | 5.2 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
2.6 | 2.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
2.6 | 7.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.6 | 7.8 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.6 | 15.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.6 | 5.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
2.6 | 10.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
2.6 | 5.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.6 | 7.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
2.6 | 10.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
2.6 | 18.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.6 | 2.6 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
2.6 | 20.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
2.6 | 7.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.6 | 7.7 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
2.6 | 7.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.6 | 2.6 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
2.5 | 20.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
2.5 | 12.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
2.5 | 2.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
2.5 | 10.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.5 | 5.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
2.5 | 10.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.5 | 2.5 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
2.5 | 2.5 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
2.5 | 20.1 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
2.5 | 5.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
2.5 | 7.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
2.5 | 10.0 | GO:0090009 | primitive streak formation(GO:0090009) |
2.5 | 2.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
2.5 | 10.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
2.5 | 2.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
2.5 | 5.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.5 | 7.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
2.5 | 5.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
2.5 | 2.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.5 | 7.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
2.5 | 7.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.5 | 4.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
2.5 | 2.5 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
2.5 | 22.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
2.5 | 12.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
2.5 | 2.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.5 | 7.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
2.5 | 4.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.4 | 2.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.4 | 12.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
2.4 | 2.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
2.4 | 9.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
2.4 | 2.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
2.4 | 12.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.4 | 2.4 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
2.4 | 12.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
2.4 | 17.0 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
2.4 | 9.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
2.4 | 19.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
2.4 | 4.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
2.4 | 2.4 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
2.4 | 2.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.4 | 12.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
2.4 | 7.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
2.4 | 9.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.4 | 2.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.4 | 21.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.4 | 2.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
2.4 | 4.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.4 | 19.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
2.4 | 9.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
2.4 | 4.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.4 | 16.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
2.4 | 9.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
2.3 | 7.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.3 | 21.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
2.3 | 4.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
2.3 | 4.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
2.3 | 9.3 | GO:0035878 | nail development(GO:0035878) |
2.3 | 2.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
2.3 | 2.3 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.3 | 11.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
2.3 | 4.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
2.3 | 2.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
2.3 | 16.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
2.3 | 11.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.3 | 4.6 | GO:0048320 | axial mesoderm formation(GO:0048320) |
2.3 | 6.9 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
2.3 | 6.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.3 | 2.3 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
2.3 | 69.3 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
2.3 | 4.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
2.3 | 23.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
2.3 | 6.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.3 | 6.9 | GO:0048069 | eye pigmentation(GO:0048069) |
2.3 | 4.6 | GO:0071280 | cellular response to copper ion(GO:0071280) |
2.3 | 20.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.3 | 6.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.3 | 4.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
2.3 | 18.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
2.3 | 4.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
2.3 | 2.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
2.3 | 4.5 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
2.3 | 6.8 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
2.3 | 2.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.2 | 11.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
2.2 | 4.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
2.2 | 4.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.2 | 11.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
2.2 | 6.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.2 | 2.2 | GO:2000677 | regulation of transcription regulatory region DNA binding(GO:2000677) |
2.2 | 17.9 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
2.2 | 4.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
2.2 | 4.5 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
2.2 | 6.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
2.2 | 2.2 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) |
2.2 | 2.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
2.2 | 15.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
2.2 | 2.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
2.2 | 8.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
2.2 | 22.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
2.2 | 6.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.2 | 24.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
2.2 | 15.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
2.2 | 11.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
2.2 | 17.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
2.2 | 15.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
2.2 | 10.8 | GO:0097459 | iron ion import into cell(GO:0097459) |
2.2 | 25.9 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
2.2 | 54.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
2.2 | 15.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
2.2 | 2.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
2.2 | 12.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.1 | 4.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
2.1 | 2.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.1 | 6.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
2.1 | 2.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
2.1 | 8.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
2.1 | 2.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
2.1 | 4.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
2.1 | 8.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) |
2.1 | 6.3 | GO:0015886 | heme transport(GO:0015886) |
2.1 | 18.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
2.1 | 6.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.1 | 14.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
2.1 | 2.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
2.1 | 8.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
2.1 | 18.8 | GO:0007097 | nuclear migration(GO:0007097) |
2.1 | 8.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
2.1 | 2.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
2.1 | 6.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.1 | 14.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
2.1 | 6.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
2.1 | 6.2 | GO:0080009 | mRNA methylation(GO:0080009) |
2.1 | 2.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
2.1 | 8.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.1 | 4.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
2.1 | 16.5 | GO:0060896 | neural plate pattern specification(GO:0060896) |
2.1 | 10.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
2.1 | 33.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
2.1 | 4.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
2.1 | 26.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
2.1 | 4.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.1 | 6.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.1 | 2.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
2.0 | 8.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
2.0 | 2.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.0 | 10.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.0 | 12.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
2.0 | 6.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.0 | 4.0 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
2.0 | 6.1 | GO:0006562 | proline catabolic process(GO:0006562) |
2.0 | 2.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
2.0 | 6.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.0 | 14.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
2.0 | 4.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
2.0 | 32.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
2.0 | 2.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.0 | 2.0 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
2.0 | 8.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
2.0 | 15.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
2.0 | 4.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.0 | 4.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
2.0 | 5.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.0 | 5.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
2.0 | 39.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
2.0 | 3.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
2.0 | 35.3 | GO:0048821 | erythrocyte development(GO:0048821) |
2.0 | 3.9 | GO:0050955 | thermoception(GO:0050955) |
2.0 | 2.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
2.0 | 7.8 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
2.0 | 17.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
2.0 | 5.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.9 | 1.9 | GO:0001839 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
1.9 | 1.9 | GO:0038066 | p38MAPK cascade(GO:0038066) |
1.9 | 3.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.9 | 7.8 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
1.9 | 5.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
1.9 | 40.8 | GO:0031648 | protein destabilization(GO:0031648) |
1.9 | 9.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.9 | 17.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
1.9 | 5.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.9 | 5.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
1.9 | 3.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.9 | 5.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.9 | 7.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.9 | 1.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.9 | 1.9 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
1.9 | 26.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.9 | 15.3 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
1.9 | 11.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.9 | 5.7 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.9 | 9.5 | GO:0009650 | UV protection(GO:0009650) |
1.9 | 5.7 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.9 | 1.9 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.9 | 7.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.9 | 7.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.9 | 1.9 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
1.9 | 1.9 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.9 | 5.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.9 | 18.6 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
1.9 | 1.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.9 | 35.3 | GO:0006953 | acute-phase response(GO:0006953) |
1.9 | 1.9 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
1.9 | 9.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.8 | 1.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.8 | 5.5 | GO:0071404 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.8 | 3.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.8 | 1.8 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
1.8 | 5.5 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
1.8 | 1.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.8 | 5.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.8 | 1.8 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
1.8 | 1.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.8 | 12.8 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.8 | 9.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
1.8 | 5.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.8 | 3.6 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
1.8 | 3.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.8 | 3.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.8 | 1.8 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
1.8 | 19.9 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.8 | 9.0 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
1.8 | 1.8 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
1.8 | 21.7 | GO:0045116 | protein neddylation(GO:0045116) |
1.8 | 12.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.8 | 3.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.8 | 3.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.8 | 12.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.8 | 16.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.8 | 5.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.8 | 12.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.8 | 7.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.8 | 10.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.8 | 7.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.8 | 7.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.8 | 1.8 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.8 | 1.8 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
1.8 | 1.8 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.8 | 5.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.8 | 1.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
1.8 | 10.5 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.8 | 3.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.8 | 8.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.8 | 8.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.8 | 5.3 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.7 | 8.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.7 | 3.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.7 | 7.0 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
1.7 | 3.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.7 | 3.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.7 | 13.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.7 | 3.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.7 | 5.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.7 | 6.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.7 | 10.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.7 | 6.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.7 | 5.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.7 | 5.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.7 | 1.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.7 | 6.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
1.7 | 3.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.7 | 5.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.7 | 6.9 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
1.7 | 5.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
1.7 | 3.4 | GO:0001774 | microglial cell activation(GO:0001774) |
1.7 | 11.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.7 | 6.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.7 | 5.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.7 | 10.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.7 | 6.8 | GO:0060613 | fat pad development(GO:0060613) |
1.7 | 6.8 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.7 | 8.5 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.7 | 1.7 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.7 | 1.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.7 | 20.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.7 | 5.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.7 | 20.2 | GO:0051601 | exocyst localization(GO:0051601) |
1.7 | 13.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
1.7 | 30.3 | GO:0014823 | response to activity(GO:0014823) |
1.7 | 3.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.7 | 6.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.7 | 8.4 | GO:0060023 | soft palate development(GO:0060023) |
1.7 | 8.4 | GO:0030033 | microvillus assembly(GO:0030033) |
1.7 | 28.4 | GO:0006491 | N-glycan processing(GO:0006491) |
1.7 | 15.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
1.7 | 1.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.7 | 1.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.7 | 3.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.7 | 3.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.7 | 20.0 | GO:0051904 | pigment granule transport(GO:0051904) |
1.7 | 6.6 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
1.7 | 3.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.7 | 1.7 | GO:0015747 | urate transport(GO:0015747) |
1.7 | 1.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.7 | 5.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.6 | 13.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
1.6 | 1.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.6 | 18.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.6 | 4.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.6 | 4.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.6 | 1.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.6 | 1.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.6 | 4.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.6 | 8.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.6 | 4.9 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
1.6 | 1.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.6 | 3.2 | GO:0007525 | somatic muscle development(GO:0007525) |
1.6 | 8.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.6 | 1.6 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.6 | 9.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
1.6 | 4.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
1.6 | 4.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.6 | 4.8 | GO:0060056 | mammary gland involution(GO:0060056) |
1.6 | 3.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.6 | 28.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.6 | 6.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.6 | 8.0 | GO:0000237 | leptotene(GO:0000237) |
1.6 | 1.6 | GO:0035973 | aggrephagy(GO:0035973) |
1.6 | 6.4 | GO:0042637 | catagen(GO:0042637) |
1.6 | 3.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.6 | 3.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.6 | 6.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.6 | 9.5 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
1.6 | 6.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.6 | 1.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
1.6 | 7.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.6 | 3.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.6 | 4.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.6 | 1.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.6 | 14.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
1.6 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.6 | 7.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.6 | 3.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.6 | 1.6 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.6 | 1.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.6 | 4.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.6 | 3.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.6 | 4.7 | GO:0009299 | mRNA transcription(GO:0009299) |
1.6 | 6.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.6 | 10.9 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
1.6 | 4.7 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.6 | 3.1 | GO:0006477 | protein sulfation(GO:0006477) |
1.5 | 3.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.5 | 3.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.5 | 1.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.5 | 10.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.5 | 12.3 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
1.5 | 3.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.5 | 6.1 | GO:0034340 | response to type I interferon(GO:0034340) |
1.5 | 1.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.5 | 6.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.5 | 12.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.5 | 3.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.5 | 7.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.5 | 3.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.5 | 3.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.5 | 12.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.5 | 3.0 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.5 | 9.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.5 | 1.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.5 | 3.0 | GO:0002215 | defense response to nematode(GO:0002215) |
1.5 | 6.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.5 | 1.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.5 | 3.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.5 | 3.0 | GO:0032252 | secretory granule localization(GO:0032252) |
1.5 | 3.0 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
1.5 | 31.4 | GO:0051591 | response to cAMP(GO:0051591) |
1.5 | 3.0 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.5 | 1.5 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
1.5 | 3.0 | GO:0033227 | dsRNA transport(GO:0033227) |
1.5 | 9.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.5 | 9.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.5 | 7.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.5 | 1.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.5 | 3.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.5 | 6.0 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
1.5 | 1.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.5 | 10.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.5 | 1.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.5 | 1.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.5 | 1.5 | GO:0042182 | ketone catabolic process(GO:0042182) |
1.5 | 14.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.5 | 4.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.5 | 11.8 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
1.5 | 10.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.5 | 1.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.5 | 1.5 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
1.5 | 7.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.5 | 4.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.5 | 8.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.5 | 5.9 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
1.5 | 7.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
1.5 | 24.8 | GO:0006301 | postreplication repair(GO:0006301) |
1.5 | 2.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.5 | 5.8 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
1.5 | 4.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.5 | 5.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.4 | 5.8 | GO:0007144 | female meiosis I(GO:0007144) |
1.4 | 36.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
1.4 | 57.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.4 | 1.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.4 | 4.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.4 | 43.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
1.4 | 5.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.4 | 2.9 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
1.4 | 4.3 | GO:1903232 | melanosome assembly(GO:1903232) |
1.4 | 4.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.4 | 4.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.4 | 10.0 | GO:0006476 | protein deacetylation(GO:0006476) |
1.4 | 5.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.4 | 7.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.4 | 1.4 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
1.4 | 5.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.4 | 4.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.4 | 4.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.4 | 4.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.4 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.4 | 1.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
1.4 | 1.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
1.4 | 2.8 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.4 | 37.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.4 | 9.8 | GO:0031054 | pre-miRNA processing(GO:0031054) |
1.4 | 67.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
1.4 | 1.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.4 | 1.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.4 | 2.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.4 | 2.8 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
1.4 | 2.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.4 | 2.8 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
1.4 | 1.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.4 | 4.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.4 | 12.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
1.4 | 13.8 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
1.4 | 15.1 | GO:0051383 | kinetochore organization(GO:0051383) |
1.4 | 2.7 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.4 | 1.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
1.4 | 2.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.4 | 1.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.4 | 2.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.4 | 16.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.3 | 2.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.3 | 9.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.3 | 9.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.3 | 12.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.3 | 1.3 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
1.3 | 2.7 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.3 | 14.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.3 | 14.6 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
1.3 | 15.9 | GO:0006465 | signal peptide processing(GO:0006465) |
1.3 | 6.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.3 | 2.6 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
1.3 | 6.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.3 | 4.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.3 | 10.6 | GO:0070269 | pyroptosis(GO:0070269) |
1.3 | 1.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.3 | 9.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
1.3 | 7.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.3 | 7.9 | GO:0097421 | liver regeneration(GO:0097421) |
1.3 | 2.6 | GO:0008078 | mesodermal cell migration(GO:0008078) |
1.3 | 2.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.3 | 1.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.3 | 2.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.3 | 2.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.3 | 7.8 | GO:0043486 | histone exchange(GO:0043486) |
1.3 | 2.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
1.3 | 1.3 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
1.3 | 3.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.3 | 9.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.3 | 24.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.3 | 1.3 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
1.3 | 41.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.3 | 2.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.3 | 1.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
1.3 | 8.9 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.3 | 8.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.3 | 3.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.3 | 1.3 | GO:0016246 | RNA interference(GO:0016246) |
1.3 | 3.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.3 | 5.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.3 | 2.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
1.3 | 6.3 | GO:0043297 | apical junction assembly(GO:0043297) |
1.3 | 2.5 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
1.3 | 2.5 | GO:0021984 | adenohypophysis development(GO:0021984) |
1.3 | 13.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.3 | 1.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.3 | 16.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
1.3 | 1.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.2 | 6.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.2 | 2.5 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
1.2 | 8.7 | GO:0034204 | lipid translocation(GO:0034204) |
1.2 | 2.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.2 | 31.1 | GO:0031424 | keratinization(GO:0031424) |
1.2 | 8.7 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
1.2 | 2.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.2 | 5.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
1.2 | 7.4 | GO:0006903 | vesicle targeting(GO:0006903) |
1.2 | 90.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
1.2 | 3.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.2 | 13.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.2 | 4.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.2 | 2.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.2 | 12.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.2 | 2.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.2 | 12.2 | GO:0017144 | drug metabolic process(GO:0017144) |
1.2 | 2.4 | GO:0001555 | oocyte growth(GO:0001555) |
1.2 | 1.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
1.2 | 3.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.2 | 8.5 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
1.2 | 1.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
1.2 | 1.2 | GO:0070384 | Harderian gland development(GO:0070384) |
1.2 | 1.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
1.2 | 4.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.2 | 3.6 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
1.2 | 21.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.2 | 7.2 | GO:0031167 | rRNA methylation(GO:0031167) |
1.2 | 1.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.2 | 2.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
1.2 | 15.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.2 | 9.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.2 | 3.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.2 | 1.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.2 | 3.6 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.2 | 1.2 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
1.2 | 1.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.2 | 1.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.2 | 4.8 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
1.2 | 3.6 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
1.2 | 8.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.2 | 9.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
1.2 | 10.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
1.2 | 4.7 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
1.2 | 2.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.2 | 1.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
1.2 | 1.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.2 | 2.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.2 | 5.9 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.2 | 3.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.2 | 7.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.2 | 1.2 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.2 | 3.5 | GO:0015889 | cobalamin transport(GO:0015889) |
1.2 | 4.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
1.2 | 2.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.2 | 11.7 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
1.2 | 3.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.2 | 2.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.2 | 5.8 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
1.2 | 3.5 | GO:0015888 | thiamine transport(GO:0015888) |
1.2 | 3.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.2 | 3.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 2.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
1.2 | 3.5 | GO:0015846 | polyamine transport(GO:0015846) |
1.2 | 16.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
1.2 | 2.3 | GO:0015705 | iodide transport(GO:0015705) |
1.2 | 18.5 | GO:0031295 | T cell costimulation(GO:0031295) |
1.2 | 1.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.2 | 4.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.2 | 11.5 | GO:0043248 | proteasome assembly(GO:0043248) |
1.2 | 17.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.1 | 3.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.1 | 17.2 | GO:0030488 | tRNA methylation(GO:0030488) |
1.1 | 1.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
1.1 | 3.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.1 | 2.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.1 | 2.3 | GO:0042756 | drinking behavior(GO:0042756) |
1.1 | 1.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.1 | 1.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.1 | 1.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.1 | 1.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.1 | 4.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
1.1 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.1 | 15.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.1 | 5.7 | GO:0046697 | decidualization(GO:0046697) |
1.1 | 5.7 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
1.1 | 2.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 1.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.1 | 1.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.1 | 7.9 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
1.1 | 9.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.1 | 5.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.1 | 11.2 | GO:0048535 | lymph node development(GO:0048535) |
1.1 | 1.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.1 | 76.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
1.1 | 12.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.1 | 5.6 | GO:0045056 | transcytosis(GO:0045056) |
1.1 | 3.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.1 | 66.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
1.1 | 6.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.1 | 1.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
1.1 | 8.9 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.1 | 7.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.1 | 5.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.1 | 8.9 | GO:0051180 | vitamin transport(GO:0051180) |
1.1 | 7.7 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.1 | 5.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.1 | 4.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.1 | 8.8 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
1.1 | 1.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.1 | 2.2 | GO:0031529 | ruffle organization(GO:0031529) |
1.1 | 8.8 | GO:0070166 | enamel mineralization(GO:0070166) |
1.1 | 13.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.1 | 2.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.1 | 2.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.1 | 1.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.1 | 1.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.1 | 2.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.1 | 10.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
1.1 | 1.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.1 | 15.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.1 | 1.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.1 | 2.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.1 | 14.1 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
1.1 | 10.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.1 | 2.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
1.1 | 1.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.1 | 2.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.1 | 3.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.1 | 7.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.1 | 3.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
1.1 | 4.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.1 | 4.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.1 | 2.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.1 | 3.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
1.1 | 2.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.1 | 3.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.1 | 2.1 | GO:0072718 | response to cisplatin(GO:0072718) |
1.1 | 2.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.1 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.1 | 11.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.1 | 1.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.1 | 10.6 | GO:0001706 | endoderm formation(GO:0001706) |
1.1 | 3.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.1 | 1.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.1 | 1.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.1 | 5.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
1.1 | 2.1 | GO:0001302 | replicative cell aging(GO:0001302) |
1.1 | 1.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.1 | 6.3 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
1.1 | 23.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.0 | 2.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.0 | 1.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.0 | 5.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
1.0 | 2.1 | GO:0031639 | plasminogen activation(GO:0031639) |
1.0 | 1.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
1.0 | 9.4 | GO:0010842 | retina layer formation(GO:0010842) |
1.0 | 7.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
1.0 | 8.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.0 | 2.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
1.0 | 1.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.0 | 5.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.0 | 8.3 | GO:0051642 | centrosome localization(GO:0051642) |
1.0 | 6.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.0 | 2.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.0 | 5.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.0 | 2.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
1.0 | 1.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.0 | 11.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.0 | 14.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.0 | 1.0 | GO:1903421 | regulation of synaptic vesicle endocytosis(GO:1900242) regulation of synaptic vesicle recycling(GO:1903421) |
1.0 | 8.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.0 | 3.1 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
1.0 | 8.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.0 | 4.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.0 | 2.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
1.0 | 3.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
1.0 | 1.0 | GO:0070254 | mucus secretion(GO:0070254) |
1.0 | 2.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
1.0 | 2.0 | GO:0070459 | prolactin secretion(GO:0070459) |
1.0 | 16.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.0 | 2.0 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.0 | 1.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
1.0 | 3.0 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
1.0 | 6.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
1.0 | 3.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
1.0 | 4.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.0 | 8.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.0 | 4.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
1.0 | 9.1 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
1.0 | 9.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 4.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.0 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.0 | 2.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.0 | 3.0 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.0 | 4.0 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.0 | 8.0 | GO:0034389 | lipid particle organization(GO:0034389) |
1.0 | 2.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.0 | 3.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 1.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.0 | 3.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.0 | 2.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.0 | 1.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.0 | 6.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.0 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.0 | 1.0 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
1.0 | 2.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.0 | 22.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.0 | 1.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
1.0 | 1.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
1.0 | 3.0 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.0 | 5.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
1.0 | 7.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
1.0 | 32.3 | GO:0006970 | response to osmotic stress(GO:0006970) |
1.0 | 3.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.0 | 1.0 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
1.0 | 5.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.0 | 3.9 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.0 | 1.0 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
1.0 | 4.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
1.0 | 7.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.0 | 1.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.0 | 9.7 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
1.0 | 6.8 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
1.0 | 4.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.0 | 2.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.0 | 9.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.0 | 1.0 | GO:0032632 | T cell proliferation involved in immune response(GO:0002309) cadmium ion transport(GO:0015691) interleukin-3 production(GO:0032632) cadmium ion transmembrane transport(GO:0070574) |
1.0 | 2.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.0 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.0 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 2.9 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.0 | 3.8 | GO:0010324 | membrane invagination(GO:0010324) |
1.0 | 1.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.0 | 2.9 | GO:0001842 | neural fold formation(GO:0001842) |
1.0 | 2.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.0 | 1.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.0 | 3.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.0 | 1.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.9 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.9 | 1.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 10.4 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.9 | 0.9 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.9 | 4.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.9 | 0.9 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.9 | 4.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.9 | 1.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.9 | 2.8 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.9 | 4.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.9 | 3.7 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.9 | 2.8 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.9 | 3.7 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.9 | 2.8 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.9 | 1.9 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.9 | 1.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.9 | 1.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.9 | 0.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.9 | 10.1 | GO:0032355 | response to estradiol(GO:0032355) |
0.9 | 0.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 0.9 | GO:0002934 | desmosome organization(GO:0002934) |
0.9 | 9.2 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.9 | 8.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.9 | 1.8 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.9 | 14.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.9 | 4.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.9 | 9.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.9 | 2.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.9 | 17.3 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.9 | 2.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.9 | 4.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.9 | 2.7 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.9 | 1.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 1.8 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.9 | 12.7 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.9 | 0.9 | GO:0071371 | response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
0.9 | 7.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.9 | 0.9 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.9 | 1.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.9 | 5.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.9 | 10.8 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.9 | 6.3 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.9 | 6.3 | GO:0007379 | segment specification(GO:0007379) |
0.9 | 1.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.9 | 7.1 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.9 | 1.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.9 | 2.7 | GO:0015744 | succinate transport(GO:0015744) |
0.9 | 5.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.9 | 4.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.9 | 0.9 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.9 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.9 | 2.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.9 | 5.3 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.9 | 1.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.9 | 3.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.9 | 2.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.9 | 17.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.9 | 0.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.9 | 7.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.9 | 2.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.9 | 1.8 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.9 | 2.6 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.9 | 4.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.9 | 0.9 | GO:2000725 | regulation of cardiac muscle cell differentiation(GO:2000725) |
0.9 | 1.7 | GO:0060900 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) embryonic camera-type eye formation(GO:0060900) |
0.9 | 0.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 | 4.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.9 | 4.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.9 | 2.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.9 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.9 | 6.9 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.9 | 0.9 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.9 | 0.9 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.9 | 12.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.9 | 14.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.8 | 3.4 | GO:0015893 | drug transport(GO:0015893) |
0.8 | 2.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.8 | 13.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.8 | 1.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.8 | 0.8 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.8 | 1.7 | GO:0032400 | melanosome localization(GO:0032400) |
0.8 | 0.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.8 | 1.7 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.8 | 2.5 | GO:0071435 | potassium ion export(GO:0071435) |
0.8 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.8 | 4.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.8 | 0.8 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.8 | 2.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.8 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.8 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.8 | 3.3 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.8 | 0.8 | GO:0043586 | tongue development(GO:0043586) |
0.8 | 1.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.8 | 0.8 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.8 | 4.2 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.8 | 4.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.8 | 2.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.8 | 6.6 | GO:0071514 | genetic imprinting(GO:0071514) |
0.8 | 4.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.8 | 0.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.8 | 1.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.8 | 2.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.8 | 5.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.8 | 2.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.8 | 22.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.8 | 1.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.8 | 0.8 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.8 | 4.9 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.8 | 0.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.8 | 4.9 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.8 | 6.5 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.8 | 0.8 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.8 | 4.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.8 | 2.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.8 | 4.1 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.8 | 4.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.8 | 4.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 1.6 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.8 | 1.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.8 | 0.8 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.8 | 1.6 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.8 | 3.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.8 | 6.4 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.8 | 3.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.8 | 3.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 2.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 7.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.8 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.8 | 1.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.8 | 0.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.8 | 0.8 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.8 | 0.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.8 | 3.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.8 | 4.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.8 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 0.8 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.8 | 2.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 3.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.8 | 4.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.8 | 1.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.8 | 1.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.8 | 4.7 | GO:0050892 | intestinal absorption(GO:0050892) |
0.8 | 0.8 | GO:0006573 | valine metabolic process(GO:0006573) |
0.8 | 0.8 | GO:0060921 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.8 | 3.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.8 | 2.3 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.8 | 8.6 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.8 | 1.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.8 | 0.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.8 | 0.8 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.8 | 2.3 | GO:0009629 | response to gravity(GO:0009629) |
0.8 | 3.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.8 | 1.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.8 | 3.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.8 | 3.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.8 | 15.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.8 | 4.6 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.8 | 2.3 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.8 | 4.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 1.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.8 | 8.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.8 | 6.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.8 | 1.5 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.8 | 5.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.8 | 1.5 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.8 | 3.0 | GO:0006560 | proline metabolic process(GO:0006560) |
0.8 | 3.8 | GO:0001556 | oocyte maturation(GO:0001556) |
0.8 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.8 | 0.8 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.8 | 8.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.8 | 2.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.8 | 0.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.8 | 4.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.8 | 1.5 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.8 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.8 | 0.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.7 | 0.7 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.7 | 6.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.7 | 10.4 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.7 | 0.7 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.7 | 3.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.7 | 0.7 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.7 | 1.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.7 | 2.2 | GO:0070542 | response to fatty acid(GO:0070542) |
0.7 | 1.5 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.7 | 5.8 | GO:0035904 | aorta development(GO:0035904) |
0.7 | 2.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.7 | 2.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.7 | 5.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.7 | 5.1 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.7 | 0.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.7 | 3.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.7 | 2.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.7 | 0.7 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.7 | 4.3 | GO:0042311 | vasodilation(GO:0042311) |
0.7 | 2.9 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.7 | 6.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.7 | 3.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.7 | 1.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.7 | 1.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.7 | 1.4 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.7 | 0.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.7 | 6.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.7 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.7 | 3.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.7 | 1.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 9.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 0.7 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.7 | 4.2 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.7 | 4.2 | GO:0033273 | response to vitamin(GO:0033273) |
0.7 | 57.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.7 | 0.7 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.7 | 2.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 0.7 | GO:1901421 | regulation of response to alcohol(GO:1901419) positive regulation of response to alcohol(GO:1901421) |
0.7 | 1.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.7 | 35.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.7 | 1.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.7 | 0.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.7 | 1.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.7 | 18.0 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.7 | 4.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 0.7 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.7 | 4.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.7 | 1.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.7 | 4.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.7 | 4.8 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.7 | 4.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.7 | 3.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.7 | 4.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.7 | 2.1 | GO:0060840 | artery development(GO:0060840) |
0.7 | 8.9 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.7 | 3.4 | GO:0007059 | chromosome segregation(GO:0007059) |
0.7 | 1.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.7 | 1.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 1.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.7 | 0.7 | GO:0060068 | vagina development(GO:0060068) |
0.7 | 5.4 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.7 | 2.7 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.7 | 1.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.7 | 0.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.7 | 8.7 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.7 | 1.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.7 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.7 | 0.7 | GO:0034728 | nucleosome organization(GO:0034728) |
0.7 | 4.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 89.3 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.7 | 3.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.7 | 0.7 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.7 | 17.3 | GO:0006909 | phagocytosis(GO:0006909) |
0.7 | 1.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.7 | 1.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.7 | 2.0 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.7 | 9.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.7 | 2.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.7 | 1.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.7 | 4.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.7 | 2.6 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.7 | 11.8 | GO:0007569 | cell aging(GO:0007569) |
0.7 | 0.7 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.7 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.7 | 2.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.7 | 3.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.7 | 5.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.7 | 1.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.7 | 3.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.6 | 1.9 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.6 | 1.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 8.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 5.2 | GO:0061515 | myeloid cell development(GO:0061515) |
0.6 | 2.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 2.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.6 | 3.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.6 | 3.2 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.6 | 1.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.6 | 1.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.6 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 1.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.6 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 19.6 | GO:0022900 | electron transport chain(GO:0022900) |
0.6 | 2.5 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.6 | 0.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.6 | 1.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 1.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.6 | 5.0 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.6 | 9.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.6 | 1.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.6 | 4.4 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.6 | 20.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.6 | 11.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.6 | 1.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 2.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 1.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.6 | 4.9 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.6 | 8.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.6 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 9.8 | GO:1901998 | toxin transport(GO:1901998) |
0.6 | 5.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.6 | 7.9 | GO:0019835 | cytolysis(GO:0019835) |
0.6 | 1.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 2.4 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.6 | 0.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.6 | 6.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.6 | 1.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 3.6 | GO:0090189 | regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.6 | 24.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.6 | 6.6 | GO:0007565 | female pregnancy(GO:0007565) |
0.6 | 1.8 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.6 | 5.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.6 | 13.8 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.6 | 28.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.6 | 2.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.6 | 3.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.6 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.6 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 7.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.6 | 3.5 | GO:0006575 | cellular modified amino acid metabolic process(GO:0006575) |
0.6 | 5.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.6 | 4.1 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.6 | 1.8 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.6 | 1.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.6 | 1.2 | GO:0072189 | ureter development(GO:0072189) |
0.6 | 21.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.6 | 3.5 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.6 | 0.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.6 | 2.3 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.6 | 5.8 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.6 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 15.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.6 | 3.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.6 | 6.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 5.8 | GO:1900182 | positive regulation of protein localization to nucleus(GO:1900182) |
0.6 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 1.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 7.5 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.6 | 6.3 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.6 | 2.3 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.6 | 1.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.6 | 1.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.6 | 0.6 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.6 | 0.6 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.6 | 9.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.6 | 1.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.6 | 2.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.6 | 1.7 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.6 | 38.3 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.6 | 1.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 4.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.6 | 6.7 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.6 | 3.9 | GO:0051693 | actin filament capping(GO:0051693) |
0.6 | 3.9 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.6 | 8.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.6 | 5.5 | GO:0006414 | translational elongation(GO:0006414) |
0.5 | 10.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 1.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 7.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.5 | 0.5 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.5 | 1.1 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 1.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.5 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.5 | 3.3 | GO:0048806 | genitalia development(GO:0048806) |
0.5 | 1.1 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.5 | 0.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 3.7 | GO:0032418 | lysosome localization(GO:0032418) |
0.5 | 4.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 1.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.5 | 2.1 | GO:0014904 | myotube cell development(GO:0014904) |
0.5 | 3.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.5 | 1.1 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
0.5 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.5 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.5 | 0.5 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.5 | 1.0 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 4.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 2.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.5 | 5.2 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.5 | 3.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 2.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 0.5 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.5 | 1.0 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.5 | 8.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.5 | 1.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 0.5 | GO:0019042 | viral latency(GO:0019042) |
0.5 | 0.5 | GO:0031929 | TOR signaling(GO:0031929) |
0.5 | 0.5 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.5 | 5.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 0.5 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.5 | 0.5 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.5 | 0.5 | GO:0032094 | response to food(GO:0032094) |
0.5 | 6.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.5 | 0.5 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.5 | 2.0 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.5 | 0.5 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.5 | 0.5 | GO:0032602 | chemokine production(GO:0032602) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 10.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 6.8 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.5 | 2.9 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.5 | 5.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.5 | 0.5 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.5 | 3.8 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.5 | 3.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 0.5 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.5 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 21.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 0.5 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.5 | 1.9 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.5 | 1.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.5 | 2.8 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.5 | 1.9 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.5 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 0.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.5 | 0.5 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.5 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 4.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.5 | 5.5 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.5 | 1.4 | GO:0015669 | gas transport(GO:0015669) |
0.5 | 0.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.5 | 1.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 2.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.5 | 20.8 | GO:0007599 | hemostasis(GO:0007599) |
0.5 | 2.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 0.9 | GO:0071467 | cellular response to pH(GO:0071467) |
0.4 | 16.8 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.4 | 1.8 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.4 | 1.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 0.9 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 1.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.4 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 88.5 | GO:0006412 | translation(GO:0006412) |
0.4 | 0.4 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 19.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.4 | 0.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.4 | 0.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.4 | 0.4 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.4 | 0.4 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.4 | 0.8 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 0.4 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.4 | 1.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.4 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.4 | 2.1 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.4 | 3.7 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.4 | 1.2 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 0.8 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.4 | 1.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.4 | 1.6 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.4 | 14.9 | GO:0002250 | adaptive immune response(GO:0002250) |
0.4 | 0.8 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 1.2 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 1.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.4 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 0.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.4 | 2.0 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.4 | 2.0 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 0.4 | GO:1990182 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) exosomal secretion(GO:1990182) |
0.4 | 0.8 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.4 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.4 | 3.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.4 | 0.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 4.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.8 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.4 | 0.4 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.4 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 3.8 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.4 | 1.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 3.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.4 | 8.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 36.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.4 | 1.5 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.4 | 0.8 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.4 | 0.4 | GO:0060759 | regulation of response to cytokine stimulus(GO:0060759) |
0.4 | 7.1 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.4 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.4 | 1.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.4 | 5.5 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 0.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 4.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.4 | 6.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 1.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.4 | 0.7 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.4 | 0.7 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.4 | 0.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.4 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 0.4 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.4 | 0.7 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.4 | 0.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 13.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.4 | 20.5 | GO:0098542 | defense response to other organism(GO:0098542) |
0.3 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.3 | GO:0060324 | face development(GO:0060324) |
0.3 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 1.7 | GO:1902106 | negative regulation of leukocyte differentiation(GO:1902106) |
0.3 | 0.7 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.3 | 0.7 | GO:0009310 | amine catabolic process(GO:0009310) |
0.3 | 3.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.3 | 3.3 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.3 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 21.3 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.3 | 0.7 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 1.0 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 0.6 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 1.0 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.3 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 0.3 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.3 | 3.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.3 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 0.3 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.3 | 1.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 2.2 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.3 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 2.2 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 4.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 3.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 0.6 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 0.6 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.3 | 3.9 | GO:0006949 | syncytium formation(GO:0006949) |
0.3 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 5.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.3 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 0.3 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.3 | 18.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.3 | 0.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 1.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 8.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 0.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.3 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.3 | 1.4 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 52.2 | GO:0048232 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.3 | 2.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 1.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.3 | 0.3 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.3 | 0.5 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 0.8 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.3 | 1.9 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.3 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.3 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.3 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.3 | 3.1 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 2.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.3 | 0.8 | GO:0048536 | spleen development(GO:0048536) |
0.3 | 0.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.3 | 0.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 1.8 | GO:0097576 | vacuole fusion(GO:0097576) |
0.3 | 0.3 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 2.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.7 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.2 | 0.7 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 2.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 0.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 0.2 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.2 | 0.2 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 1.9 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.2 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.7 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 2.0 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.2 | 5.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 2.7 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 0.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 2.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.3 | GO:0045137 | development of primary sexual characteristics(GO:0045137) |
0.2 | 1.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.2 | GO:0072132 | mesenchyme morphogenesis(GO:0072132) |
0.2 | 0.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.2 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.2 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.9 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.6 | GO:0006304 | DNA modification(GO:0006304) |
0.2 | 1.2 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.2 | 0.4 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.2 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.2 | 0.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 0.2 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.2 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.6 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.2 | 0.6 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 0.7 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.2 | 6.4 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.2 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.2 | 0.2 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.2 | 3.8 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 2.4 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.2 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.2 | 0.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 1.5 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.8 | GO:0043588 | skin development(GO:0043588) |
0.2 | 0.7 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.3 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.2 | 0.2 | GO:0051177 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 0.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.2 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.2 | 0.2 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.1 | 1.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 1.6 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.3 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.9 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 9.5 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 4.3 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.1 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.7 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 13.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 3.4 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:0070192 | chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.4 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 1.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.1 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.5 | GO:0030217 | T cell differentiation(GO:0030217) |
0.1 | 0.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.1 | 0.5 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.3 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway(GO:2001242) |
0.1 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 1.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 0.2 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.1 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 2.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.6 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.8 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 3.0 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 0.4 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.1 | 0.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 3.4 | GO:0006954 | inflammatory response(GO:0006954) |
0.1 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.8 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.1 | 2.3 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 3.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.9 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 0.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.1 | 2.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.9 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 0.4 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 3.6 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.1 | 0.1 | GO:0090505 | wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 6.9 | GO:0051301 | cell division(GO:0051301) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 5.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 5.7 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
0.0 | 0.0 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.8 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 0.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.1 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.1 | GO:0042159 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 1.3 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.0 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.0 | 6.9 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 13.4 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.0 | 47.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
14.3 | 57.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
9.2 | 36.7 | GO:0033269 | internode region of axon(GO:0033269) |
7.4 | 44.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
7.2 | 21.5 | GO:0005914 | spot adherens junction(GO:0005914) |
7.1 | 21.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
7.0 | 42.2 | GO:0043219 | lateral loop(GO:0043219) |
6.7 | 53.9 | GO:0030056 | hemidesmosome(GO:0030056) |
6.6 | 13.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
6.5 | 19.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
6.4 | 6.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
6.2 | 112.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
6.2 | 18.6 | GO:0008091 | spectrin(GO:0008091) |
5.9 | 29.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
5.8 | 46.6 | GO:0045179 | apical cortex(GO:0045179) |
5.7 | 80.5 | GO:0031528 | microvillus membrane(GO:0031528) |
5.5 | 22.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
5.4 | 21.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
5.3 | 21.2 | GO:1990357 | terminal web(GO:1990357) |
5.2 | 31.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
5.1 | 5.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.7 | 14.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
4.6 | 18.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
4.6 | 13.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
4.4 | 13.3 | GO:0097513 | myosin II filament(GO:0097513) |
4.2 | 12.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
4.1 | 12.4 | GO:0030008 | TRAPP complex(GO:0030008) |
3.9 | 11.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
3.9 | 15.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.9 | 19.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
3.8 | 15.1 | GO:0072487 | MSL complex(GO:0072487) |
3.7 | 22.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
3.6 | 32.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.5 | 3.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
3.5 | 13.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
3.5 | 24.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
3.3 | 16.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
3.3 | 26.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
3.2 | 22.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.2 | 12.8 | GO:0030689 | Noc complex(GO:0030689) |
3.2 | 6.4 | GO:0031523 | Myb complex(GO:0031523) |
3.2 | 16.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
3.2 | 22.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.2 | 15.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.2 | 6.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
3.1 | 22.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
3.1 | 9.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
3.1 | 3.1 | GO:0005911 | cell-cell junction(GO:0005911) |
3.1 | 24.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
3.1 | 9.3 | GO:0048179 | activin receptor complex(GO:0048179) |
3.1 | 12.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
3.1 | 15.3 | GO:0005638 | lamin filament(GO:0005638) |
3.1 | 340.0 | GO:0005903 | brush border(GO:0005903) |
3.1 | 9.2 | GO:0044456 | synapse part(GO:0044456) |
3.0 | 21.0 | GO:0097470 | ribbon synapse(GO:0097470) |
3.0 | 9.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.9 | 2.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
2.9 | 8.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.9 | 32.2 | GO:0042581 | specific granule(GO:0042581) |
2.9 | 5.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
2.9 | 8.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.8 | 22.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.8 | 11.3 | GO:0035363 | histone locus body(GO:0035363) |
2.8 | 8.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.8 | 13.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.8 | 11.0 | GO:0098536 | deuterosome(GO:0098536) |
2.7 | 5.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.7 | 21.8 | GO:0001939 | female pronucleus(GO:0001939) |
2.7 | 5.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.6 | 26.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
2.6 | 5.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
2.6 | 13.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.6 | 12.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.6 | 2.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.5 | 25.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.5 | 5.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
2.5 | 12.5 | GO:0005827 | polar microtubule(GO:0005827) |
2.5 | 19.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
2.5 | 14.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.4 | 7.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.4 | 14.5 | GO:0071439 | clathrin complex(GO:0071439) |
2.4 | 16.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.4 | 7.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.4 | 72.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.4 | 9.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
2.4 | 4.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.4 | 23.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
2.3 | 90.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
2.3 | 9.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
2.3 | 20.8 | GO:0070852 | cell body fiber(GO:0070852) |
2.3 | 11.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
2.3 | 16.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
2.3 | 6.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
2.3 | 6.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.3 | 20.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.2 | 20.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.2 | 6.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.2 | 66.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.2 | 2.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.2 | 10.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.2 | 15.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
2.2 | 10.8 | GO:0097433 | dense body(GO:0097433) |
2.2 | 17.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.1 | 10.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.1 | 29.9 | GO:0031011 | Ino80 complex(GO:0031011) |
2.1 | 17.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.1 | 6.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.1 | 14.8 | GO:0005688 | U6 snRNP(GO:0005688) |
2.1 | 4.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.1 | 92.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
2.1 | 8.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.1 | 97.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
2.1 | 24.7 | GO:0061702 | inflammasome complex(GO:0061702) |
2.1 | 8.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
2.1 | 8.2 | GO:1990130 | Iml1 complex(GO:1990130) |
2.1 | 4.1 | GO:0016939 | kinesin II complex(GO:0016939) |
2.1 | 2.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.0 | 6.1 | GO:0016600 | flotillin complex(GO:0016600) |
2.0 | 8.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.0 | 2.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.0 | 13.9 | GO:0005652 | nuclear lamina(GO:0005652) |
2.0 | 5.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.0 | 47.1 | GO:0034451 | centriolar satellite(GO:0034451) |
2.0 | 127.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.9 | 13.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.9 | 5.8 | GO:0097413 | Lewy body(GO:0097413) |
1.9 | 27.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.9 | 5.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.9 | 5.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.9 | 75.2 | GO:0032587 | ruffle membrane(GO:0032587) |
1.9 | 19.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.9 | 25.0 | GO:0030914 | STAGA complex(GO:0030914) |
1.9 | 15.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.9 | 7.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.9 | 5.7 | GO:0071437 | invadopodium(GO:0071437) |
1.9 | 3.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.9 | 26.2 | GO:0001891 | phagocytic cup(GO:0001891) |
1.9 | 1.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.9 | 13.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.8 | 11.1 | GO:0042627 | chylomicron(GO:0042627) |
1.8 | 23.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.8 | 5.4 | GO:0000811 | GINS complex(GO:0000811) |
1.8 | 7.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.8 | 16.2 | GO:0031932 | TORC2 complex(GO:0031932) |
1.8 | 18.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.8 | 5.4 | GO:0070069 | cytochrome complex(GO:0070069) |
1.8 | 5.3 | GO:0031417 | NatC complex(GO:0031417) |
1.8 | 21.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.8 | 92.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.7 | 7.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.7 | 8.7 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.7 | 5.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.7 | 1.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.7 | 8.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.7 | 13.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.7 | 29.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.7 | 8.5 | GO:0044327 | dendritic spine head(GO:0044327) |
1.7 | 3.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.7 | 10.1 | GO:0090543 | Flemming body(GO:0090543) |
1.7 | 1.7 | GO:1990423 | RZZ complex(GO:1990423) |
1.7 | 1.7 | GO:0043293 | apoptosome(GO:0043293) |
1.6 | 24.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.6 | 8.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.6 | 26.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.6 | 87.7 | GO:0005811 | lipid particle(GO:0005811) |
1.6 | 3.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.6 | 1.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.6 | 45.0 | GO:0031901 | early endosome membrane(GO:0031901) |
1.6 | 135.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.6 | 8.0 | GO:0042587 | glycogen granule(GO:0042587) |
1.6 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.6 | 7.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 7.8 | GO:0033263 | CORVET complex(GO:0033263) |
1.5 | 10.8 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.5 | 17.0 | GO:0097440 | apical dendrite(GO:0097440) |
1.5 | 16.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.5 | 108.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
1.5 | 4.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.5 | 25.7 | GO:0043034 | costamere(GO:0043034) |
1.5 | 6.1 | GO:0000242 | pericentriolar material(GO:0000242) |
1.5 | 40.7 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
1.5 | 6.0 | GO:0071565 | nBAF complex(GO:0071565) |
1.5 | 4.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.5 | 3.0 | GO:0005767 | secondary lysosome(GO:0005767) |
1.5 | 10.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.5 | 39.8 | GO:0016592 | mediator complex(GO:0016592) |
1.5 | 10.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 4.4 | GO:0000812 | Swr1 complex(GO:0000812) |
1.5 | 5.8 | GO:0042825 | TAP complex(GO:0042825) |
1.5 | 84.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.4 | 4.3 | GO:0038201 | TOR complex(GO:0038201) |
1.4 | 2.9 | GO:0005955 | calcineurin complex(GO:0005955) |
1.4 | 4.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.4 | 27.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.4 | 32.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.4 | 1.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.4 | 4.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.4 | 8.5 | GO:0005796 | Golgi lumen(GO:0005796) |
1.4 | 5.6 | GO:0030891 | VCB complex(GO:0030891) |
1.4 | 4.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.4 | 12.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.4 | 4.1 | GO:0030894 | replisome(GO:0030894) |
1.4 | 1.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.4 | 4.1 | GO:0070938 | contractile ring(GO:0070938) |
1.4 | 4.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.4 | 9.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.4 | 32.9 | GO:0001772 | immunological synapse(GO:0001772) |
1.4 | 4.1 | GO:0031983 | vesicle lumen(GO:0031983) |
1.4 | 5.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.4 | 4.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.4 | 40.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.3 | 18.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.3 | 13.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.3 | 2.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.3 | 2.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.3 | 47.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.3 | 14.6 | GO:0005901 | caveola(GO:0005901) |
1.3 | 7.9 | GO:0031512 | motile primary cilium(GO:0031512) |
1.3 | 25.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
1.3 | 28.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.3 | 3.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.3 | 1.3 | GO:0071817 | MMXD complex(GO:0071817) |
1.3 | 5.2 | GO:1990745 | EARP complex(GO:1990745) |
1.3 | 3.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.3 | 7.8 | GO:0030057 | desmosome(GO:0030057) |
1.3 | 1.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.3 | 11.6 | GO:0031143 | pseudopodium(GO:0031143) |
1.3 | 6.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.3 | 3.9 | GO:0030027 | lamellipodium(GO:0030027) |
1.3 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.3 | 19.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.3 | 2.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.3 | 7.7 | GO:0005818 | aster(GO:0005818) |
1.3 | 107.6 | GO:0072562 | blood microparticle(GO:0072562) |
1.3 | 2.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.3 | 48.5 | GO:0016363 | nuclear matrix(GO:0016363) |
1.3 | 3.8 | GO:0034709 | methylosome(GO:0034709) |
1.3 | 1.3 | GO:0016234 | inclusion body(GO:0016234) |
1.3 | 27.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.3 | 13.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.3 | 10.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.3 | 52.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.3 | 2.5 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.3 | 3.8 | GO:0097452 | GAIT complex(GO:0097452) |
1.2 | 13.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.2 | 155.5 | GO:0000139 | Golgi membrane(GO:0000139) |
1.2 | 3.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.2 | 5.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.2 | 7.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
1.2 | 3.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.2 | 3.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.2 | 4.9 | GO:0031090 | organelle membrane(GO:0031090) |
1.2 | 64.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.2 | 3.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 27.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.2 | 13.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.2 | 9.6 | GO:0010369 | chromocenter(GO:0010369) |
1.2 | 14.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.2 | 7.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.2 | 4.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.2 | 70.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.2 | 3.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.2 | 13.0 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
1.2 | 11.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.2 | 7.1 | GO:0001650 | fibrillar center(GO:0001650) |
1.2 | 1.2 | GO:0005686 | U2 snRNP(GO:0005686) |
1.2 | 23.5 | GO:0016235 | aggresome(GO:0016235) |
1.2 | 3.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.2 | 5.8 | GO:0070652 | HAUS complex(GO:0070652) |
1.2 | 10.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.2 | 40.6 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.2 | 16.2 | GO:0000145 | exocyst(GO:0000145) |
1.2 | 6.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.2 | 2.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.2 | 3.5 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) BAF-type complex(GO:0090544) |
1.2 | 16.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.1 | 32.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.1 | 13.8 | GO:0036038 | MKS complex(GO:0036038) |
1.1 | 25.2 | GO:0005776 | autophagosome(GO:0005776) |
1.1 | 99.9 | GO:0005694 | chromosome(GO:0005694) |
1.1 | 3.4 | GO:0044194 | cytolytic granule(GO:0044194) |
1.1 | 26.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.1 | 10.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.1 | 12.4 | GO:0000502 | proteasome complex(GO:0000502) |
1.1 | 13.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.1 | 4.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
1.1 | 13.4 | GO:0000786 | nucleosome(GO:0000786) |
1.1 | 7.8 | GO:0016272 | prefoldin complex(GO:0016272) |
1.1 | 5.5 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 4.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.1 | 81.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.1 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.1 | 1.1 | GO:0070545 | PeBoW complex(GO:0070545) |
1.1 | 128.9 | GO:0005925 | focal adhesion(GO:0005925) |
1.1 | 5.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.1 | 12.1 | GO:0043196 | varicosity(GO:0043196) |
1.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
1.1 | 2.2 | GO:1990923 | PET complex(GO:1990923) |
1.1 | 2.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.1 | 8.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.1 | 353.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.1 | 60.7 | GO:0000793 | condensed chromosome(GO:0000793) |
1.1 | 3.2 | GO:1990635 | proximal dendrite(GO:1990635) |
1.1 | 3.2 | GO:0072687 | meiotic spindle(GO:0072687) |
1.1 | 19.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.1 | 8.5 | GO:0032797 | SMN complex(GO:0032797) |
1.1 | 56.9 | GO:0005643 | nuclear pore(GO:0005643) |
1.0 | 8.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.0 | 16.8 | GO:0005902 | microvillus(GO:0005902) |
1.0 | 2.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 3.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.0 | 73.9 | GO:0000776 | kinetochore(GO:0000776) |
1.0 | 1184.7 | GO:0005654 | nucleoplasm(GO:0005654) |
1.0 | 5.2 | GO:0016459 | myosin complex(GO:0016459) |
1.0 | 23.8 | GO:0012505 | endomembrane system(GO:0012505) |
1.0 | 1868.0 | GO:0070062 | extracellular exosome(GO:0070062) |
1.0 | 4.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
1.0 | 2.0 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
1.0 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.0 | 26.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.0 | 3.0 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
1.0 | 1.0 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
1.0 | 1.0 | GO:0031252 | cell leading edge(GO:0031252) |
1.0 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.9 | 2.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.9 | 15.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.9 | 58.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.9 | 4.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.9 | 3.7 | GO:0071547 | piP-body(GO:0071547) |
0.9 | 5.6 | GO:0008305 | integrin complex(GO:0008305) |
0.9 | 6.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.9 | 15.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.9 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.9 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.9 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.9 | 4.5 | GO:0042599 | lamellar body(GO:0042599) |
0.9 | 1.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.9 | 7.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.9 | 87.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.9 | 7.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.9 | 17.4 | GO:0005844 | polysome(GO:0005844) |
0.9 | 49.5 | GO:0005769 | early endosome(GO:0005769) |
0.9 | 3.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.9 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.9 | 2.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.9 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.8 | 10.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.8 | 4.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.8 | 0.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.8 | 3.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.8 | 8.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.8 | 3.3 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.8 | 3.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.8 | 2.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.8 | 2.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.8 | 1.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.8 | 95.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.8 | 21.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.8 | 25.7 | GO:0005938 | cell cortex(GO:0005938) |
0.8 | 3.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.8 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.8 | 508.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.8 | 6.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.8 | 2.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.8 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.8 | 14.8 | GO:0045095 | keratin filament(GO:0045095) |
0.8 | 2.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 0.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 7.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.7 | 1.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.7 | 5.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.7 | 4.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 159.6 | GO:0005730 | nucleolus(GO:0005730) |
0.7 | 3.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 4.3 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 1.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.7 | 2.8 | GO:0005770 | late endosome(GO:0005770) |
0.7 | 9.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.7 | 13.2 | GO:0005604 | basement membrane(GO:0005604) |
0.7 | 6.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.7 | 1.4 | GO:0089701 | U2AF(GO:0089701) |
0.7 | 6.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.7 | 2.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.7 | 439.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.7 | 2.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 275.2 | GO:0005829 | cytosol(GO:0005829) |
0.7 | 2.6 | GO:0002177 | manchette(GO:0002177) |
0.6 | 1.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 11.9 | GO:0030286 | dynein complex(GO:0030286) |
0.6 | 10.0 | GO:0032420 | stereocilium(GO:0032420) |
0.6 | 1.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 8.6 | GO:0005813 | centrosome(GO:0005813) |
0.6 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 15.0 | GO:0005814 | centriole(GO:0005814) |
0.5 | 65.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.5 | 1.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.5 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 2.1 | GO:0072372 | primary cilium(GO:0072372) |
0.5 | 1.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.5 | 6.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.5 | 46.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.5 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 1.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 1.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 12.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.5 | 267.0 | GO:0005615 | extracellular space(GO:0005615) |
0.5 | 2.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 14.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.5 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.5 | 3.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 756.0 | GO:0005634 | nucleus(GO:0005634) |
0.4 | 0.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 0.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 37.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 1.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 57.0 | GO:0005623 | cell(GO:0005623) |
0.3 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 1.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 463.7 | GO:0005737 | cytoplasm(GO:0005737) |
0.3 | 2.5 | GO:0044309 | neuron spine(GO:0044309) |
0.3 | 115.1 | GO:0005576 | extracellular region(GO:0005576) |
0.3 | 707.1 | GO:0016020 | membrane(GO:0016020) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 36.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
10.3 | 31.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
9.9 | 29.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
8.7 | 26.0 | GO:0048030 | disaccharide binding(GO:0048030) |
7.7 | 23.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
7.6 | 38.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
7.1 | 21.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
7.1 | 21.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
6.9 | 20.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.9 | 48.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
6.9 | 27.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
6.6 | 26.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
6.3 | 31.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
6.2 | 24.8 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
6.2 | 18.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
6.1 | 18.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
6.0 | 30.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
5.9 | 23.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
5.7 | 17.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
5.6 | 22.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
5.5 | 44.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
5.5 | 16.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
5.4 | 16.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
5.3 | 42.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
5.3 | 21.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
5.2 | 15.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
5.2 | 31.3 | GO:0038132 | neuregulin binding(GO:0038132) |
5.2 | 25.8 | GO:0008430 | selenium binding(GO:0008430) |
5.1 | 20.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
5.1 | 30.5 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
5.0 | 20.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
5.0 | 24.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
4.9 | 29.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
4.9 | 4.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
4.8 | 14.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
4.7 | 14.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
4.7 | 23.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
4.7 | 14.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
4.6 | 4.6 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
4.6 | 13.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
4.6 | 18.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
4.6 | 13.8 | GO:1990188 | euchromatin binding(GO:1990188) |
4.6 | 32.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
4.6 | 13.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
4.5 | 9.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
4.5 | 13.6 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
4.5 | 18.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
4.5 | 76.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
4.5 | 13.4 | GO:0004359 | glutaminase activity(GO:0004359) |
4.4 | 31.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.4 | 22.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
4.3 | 17.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
4.3 | 43.3 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
4.3 | 30.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
4.3 | 21.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
4.3 | 12.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
4.2 | 16.9 | GO:0042731 | PH domain binding(GO:0042731) |
4.2 | 4.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.2 | 12.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
4.1 | 12.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
4.1 | 20.6 | GO:0070061 | fructose binding(GO:0070061) |
4.1 | 28.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
4.0 | 8.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
4.0 | 23.9 | GO:0016936 | galactoside binding(GO:0016936) |
3.9 | 23.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.9 | 11.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.9 | 3.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.9 | 19.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
3.8 | 15.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
3.8 | 19.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
3.8 | 3.8 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
3.8 | 37.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.7 | 41.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
3.7 | 11.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
3.7 | 11.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
3.7 | 22.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.7 | 18.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
3.7 | 7.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
3.7 | 11.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
3.7 | 11.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.7 | 14.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
3.6 | 14.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
3.6 | 10.9 | GO:0043199 | sulfate binding(GO:0043199) |
3.6 | 14.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
3.6 | 10.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
3.6 | 10.8 | GO:0035877 | death effector domain binding(GO:0035877) |
3.6 | 24.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
3.5 | 14.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.5 | 21.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
3.5 | 10.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.5 | 10.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.5 | 3.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.5 | 20.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.4 | 3.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
3.4 | 24.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
3.4 | 10.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
3.4 | 3.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.4 | 6.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
3.4 | 10.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
3.3 | 10.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.3 | 9.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
3.3 | 45.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
3.3 | 19.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
3.3 | 26.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
3.3 | 16.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
3.3 | 9.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
3.2 | 19.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
3.2 | 3.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
3.2 | 64.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
3.2 | 3.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
3.2 | 9.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.2 | 25.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
3.2 | 28.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
3.2 | 44.2 | GO:0043274 | phospholipase binding(GO:0043274) |
3.2 | 9.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.1 | 6.3 | GO:0015250 | water channel activity(GO:0015250) |
3.1 | 9.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
3.1 | 21.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.1 | 12.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.1 | 12.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
3.1 | 9.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
3.1 | 12.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
3.1 | 12.3 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
3.1 | 30.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
3.0 | 6.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
3.0 | 9.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
3.0 | 15.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
3.0 | 27.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
3.0 | 6.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
3.0 | 27.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
3.0 | 26.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
2.9 | 14.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.9 | 8.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
2.9 | 14.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.9 | 8.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.9 | 8.7 | GO:0008142 | oxysterol binding(GO:0008142) |
2.9 | 11.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.9 | 8.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
2.9 | 2.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.9 | 11.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.9 | 8.6 | GO:0097016 | L27 domain binding(GO:0097016) |
2.9 | 25.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.9 | 14.3 | GO:0005499 | vitamin D binding(GO:0005499) |
2.8 | 8.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.8 | 8.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
2.8 | 2.8 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.8 | 22.4 | GO:0017166 | vinculin binding(GO:0017166) |
2.8 | 5.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.8 | 11.2 | GO:0009374 | biotin binding(GO:0009374) |
2.8 | 8.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
2.8 | 38.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.8 | 49.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
2.8 | 2.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.8 | 44.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
2.7 | 24.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
2.7 | 21.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.7 | 5.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.7 | 72.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
2.7 | 45.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
2.7 | 8.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.7 | 5.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.7 | 8.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
2.7 | 8.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
2.7 | 21.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
2.6 | 18.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.6 | 10.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
2.6 | 18.5 | GO:0005113 | patched binding(GO:0005113) |
2.6 | 21.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.6 | 10.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.6 | 13.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.6 | 10.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
2.6 | 18.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.6 | 13.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.6 | 10.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.6 | 10.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
2.6 | 7.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
2.6 | 291.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
2.6 | 2.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.6 | 23.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.6 | 10.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.6 | 7.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.6 | 7.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.6 | 7.7 | GO:0055100 | adiponectin binding(GO:0055100) |
2.5 | 43.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
2.5 | 35.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.5 | 7.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
2.5 | 5.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.5 | 5.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.5 | 12.5 | GO:0017040 | ceramidase activity(GO:0017040) |
2.5 | 29.9 | GO:0010181 | FMN binding(GO:0010181) |
2.5 | 19.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.5 | 24.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
2.5 | 7.4 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.4 | 12.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.4 | 7.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.4 | 7.3 | GO:0034618 | arginine binding(GO:0034618) |
2.4 | 39.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
2.4 | 9.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.4 | 7.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
2.4 | 2.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
2.4 | 4.8 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
2.4 | 19.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
2.4 | 9.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.4 | 7.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.4 | 2.4 | GO:0015927 | trehalase activity(GO:0015927) |
2.4 | 18.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.4 | 7.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.4 | 7.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
2.3 | 11.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
2.3 | 14.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.3 | 2.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.3 | 23.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
2.3 | 18.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
2.3 | 11.5 | GO:0032052 | bile acid binding(GO:0032052) |
2.3 | 13.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.3 | 11.5 | GO:0000150 | recombinase activity(GO:0000150) |
2.3 | 6.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
2.3 | 18.3 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
2.3 | 6.8 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.3 | 6.8 | GO:0004064 | arylesterase activity(GO:0004064) |
2.3 | 4.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.3 | 6.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.2 | 9.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.2 | 6.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.2 | 13.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.2 | 13.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.2 | 30.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
2.2 | 6.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.2 | 26.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
2.2 | 17.5 | GO:0046977 | TAP binding(GO:0046977) |
2.2 | 84.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
2.2 | 10.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.2 | 6.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.2 | 30.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
2.2 | 6.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.1 | 6.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
2.1 | 21.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
2.1 | 12.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.1 | 8.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.1 | 12.8 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
2.1 | 14.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
2.1 | 29.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
2.1 | 40.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.1 | 6.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.1 | 4.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.1 | 21.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
2.1 | 29.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.1 | 19.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
2.1 | 4.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
2.1 | 25.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.1 | 2.1 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.1 | 12.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
2.1 | 18.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.1 | 12.5 | GO:0008199 | ferric iron binding(GO:0008199) |
2.1 | 12.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.1 | 18.7 | GO:0038191 | neuropilin binding(GO:0038191) |
2.1 | 4.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
2.1 | 2.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.1 | 6.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
2.0 | 8.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
2.0 | 24.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
2.0 | 4.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
2.0 | 6.1 | GO:0019961 | interferon binding(GO:0019961) |
2.0 | 42.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
2.0 | 6.1 | GO:0019002 | GMP binding(GO:0019002) |
2.0 | 6.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.0 | 38.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
2.0 | 8.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
2.0 | 22.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.0 | 18.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
2.0 | 2.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
2.0 | 2.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
2.0 | 20.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.0 | 4.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
2.0 | 6.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
2.0 | 12.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.0 | 19.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.0 | 5.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.0 | 5.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.0 | 3.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
2.0 | 13.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
2.0 | 17.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.0 | 21.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.9 | 13.6 | GO:0031386 | protein tag(GO:0031386) |
1.9 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.9 | 1.9 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.9 | 5.8 | GO:0050692 | DBD domain binding(GO:0050692) |
1.9 | 5.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.9 | 30.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.9 | 15.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.9 | 26.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.9 | 15.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.9 | 17.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.9 | 18.7 | GO:0019841 | retinol binding(GO:0019841) |
1.9 | 7.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.9 | 1.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.9 | 1.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.9 | 24.2 | GO:0015643 | toxic substance binding(GO:0015643) |
1.9 | 3.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.9 | 29.7 | GO:0008483 | transaminase activity(GO:0008483) |
1.9 | 7.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.8 | 48.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.8 | 5.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.8 | 62.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.8 | 5.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.8 | 12.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.8 | 5.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.8 | 21.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.8 | 63.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.8 | 9.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.8 | 5.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.8 | 21.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.8 | 7.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.8 | 41.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.8 | 5.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.8 | 8.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.8 | 8.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.8 | 5.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.8 | 1.8 | GO:0019842 | vitamin binding(GO:0019842) |
1.8 | 7.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.8 | 10.5 | GO:0050700 | CARD domain binding(GO:0050700) |
1.8 | 3.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.8 | 22.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.8 | 3.5 | GO:0051184 | cofactor transporter activity(GO:0051184) |
1.8 | 15.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.8 | 29.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.8 | 7.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.8 | 3.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.8 | 5.3 | GO:0016015 | morphogen activity(GO:0016015) |
1.7 | 8.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.7 | 7.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.7 | 39.8 | GO:0030507 | spectrin binding(GO:0030507) |
1.7 | 12.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.7 | 278.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.7 | 44.7 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.7 | 6.9 | GO:0035197 | siRNA binding(GO:0035197) |
1.7 | 24.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.7 | 10.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
1.7 | 3.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.7 | 8.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.7 | 10.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
1.7 | 23.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.7 | 18.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.7 | 6.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
1.7 | 21.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.7 | 3.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.7 | 11.7 | GO:0015266 | protein channel activity(GO:0015266) |
1.7 | 23.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.7 | 8.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
1.7 | 5.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.7 | 1.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.7 | 8.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.7 | 28.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.7 | 3.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.7 | 3.3 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
1.6 | 34.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.6 | 1.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.6 | 3.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.6 | 14.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.6 | 4.9 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
1.6 | 6.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.6 | 12.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.6 | 14.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.6 | 41.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
1.6 | 15.9 | GO:0008143 | poly(A) binding(GO:0008143) |
1.6 | 1.6 | GO:0019862 | IgA binding(GO:0019862) |
1.6 | 3.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.6 | 11.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.6 | 7.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.6 | 6.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.6 | 11.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.6 | 25.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.6 | 4.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.6 | 31.2 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
1.6 | 1.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.5 | 54.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
1.5 | 7.7 | GO:0043495 | protein anchor(GO:0043495) |
1.5 | 180.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.5 | 12.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
1.5 | 78.3 | GO:0005518 | collagen binding(GO:0005518) |
1.5 | 7.6 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.5 | 7.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.5 | 22.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.5 | 1.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
1.5 | 6.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.5 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.5 | 4.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.5 | 3.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.5 | 6.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.5 | 4.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.5 | 12.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.5 | 13.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.5 | 16.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.5 | 1.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.5 | 5.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.5 | 38.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.5 | 4.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.5 | 36.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.5 | 8.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.5 | 2.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.5 | 38.3 | GO:0070888 | E-box binding(GO:0070888) |
1.5 | 5.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.5 | 7.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.5 | 14.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.5 | 5.8 | GO:0030515 | snoRNA binding(GO:0030515) |
1.5 | 16.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.5 | 5.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.4 | 10.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.4 | 2.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.4 | 4.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.4 | 2.9 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
1.4 | 11.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.4 | 4.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.4 | 41.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.4 | 18.6 | GO:0045296 | cadherin binding(GO:0045296) |
1.4 | 2.9 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
1.4 | 2.9 | GO:0038100 | nodal binding(GO:0038100) |
1.4 | 2.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.4 | 2.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.4 | 31.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.4 | 7.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.4 | 2.8 | GO:0045340 | mercury ion binding(GO:0045340) |
1.4 | 1.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.4 | 5.6 | GO:0045545 | syndecan binding(GO:0045545) |
1.4 | 5.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.4 | 5.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.4 | 104.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
1.4 | 1.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.4 | 50.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.4 | 6.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.4 | 45.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
1.4 | 2.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.4 | 12.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.4 | 18.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.4 | 19.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.4 | 12.4 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
1.4 | 4.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.4 | 5.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.4 | 8.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
1.4 | 8.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.4 | 2.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
1.4 | 6.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.4 | 8.2 | GO:0070402 | NADPH binding(GO:0070402) |
1.4 | 12.3 | GO:0035198 | miRNA binding(GO:0035198) |
1.4 | 43.7 | GO:0051015 | actin filament binding(GO:0051015) |
1.4 | 4.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.4 | 25.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
1.3 | 2.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.3 | 25.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.3 | 2.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.3 | 5.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.3 | 21.4 | GO:0045502 | dynein binding(GO:0045502) |
1.3 | 4.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 5.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.3 | 10.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.3 | 9.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.3 | 7.8 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.3 | 35.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.3 | 9.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.3 | 32.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
1.3 | 38.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.3 | 5.1 | GO:0046790 | virion binding(GO:0046790) |
1.3 | 3.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.3 | 6.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.3 | 5.1 | GO:0031013 | troponin I binding(GO:0031013) |
1.3 | 2.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.3 | 5.1 | GO:0035473 | lipase binding(GO:0035473) |
1.3 | 11.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.3 | 3.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.3 | 1.3 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
1.3 | 8.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.3 | 7.6 | GO:0032451 | demethylase activity(GO:0032451) |
1.3 | 5.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
1.3 | 2.5 | GO:0045182 | translation regulator activity(GO:0045182) |
1.3 | 12.6 | GO:0005542 | folic acid binding(GO:0005542) |
1.2 | 12.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.2 | 5.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.2 | 3.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.2 | 2.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.2 | 8.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.2 | 32.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.2 | 12.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.2 | 3.7 | GO:0005534 | galactose binding(GO:0005534) |
1.2 | 6.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.2 | 3.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.2 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
1.2 | 13.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.2 | 4.9 | GO:0034046 | poly(G) binding(GO:0034046) |
1.2 | 12.2 | GO:0005521 | lamin binding(GO:0005521) |
1.2 | 7.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.2 | 20.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.2 | 2.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.2 | 6.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.2 | 1.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.2 | 8.4 | GO:0043236 | laminin binding(GO:0043236) |
1.2 | 33.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
1.2 | 21.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.2 | 7.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.2 | 11.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 4.7 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.2 | 2.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.2 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.2 | 4.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.2 | 30.4 | GO:0043621 | protein self-association(GO:0043621) |
1.2 | 4.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.2 | 3.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.2 | 3.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.2 | 6.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.2 | 216.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.2 | 27.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.2 | 78.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.2 | 2.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 5.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.2 | 10.4 | GO:0005123 | death receptor binding(GO:0005123) |
1.1 | 78.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
1.1 | 4.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.1 | 3.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.1 | 5.7 | GO:0000182 | rDNA binding(GO:0000182) |
1.1 | 9.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.1 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.1 | 6.8 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.1 | 4.5 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.1 | 28.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.1 | 7.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.1 | 6.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.1 | 45.0 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
1.1 | 6.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.1 | 3.3 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.1 | 6.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.1 | 11.1 | GO:0048038 | quinone binding(GO:0048038) |
1.1 | 22.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.1 | 14.3 | GO:0015026 | coreceptor activity(GO:0015026) |
1.1 | 6.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.1 | 3.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.1 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
1.1 | 1.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.1 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.1 | 4.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.1 | 21.7 | GO:0030145 | manganese ion binding(GO:0030145) |
1.1 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
1.1 | 24.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.1 | 11.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.1 | 102.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
1.1 | 3.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.1 | 52.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.1 | 3.2 | GO:0001846 | opsonin binding(GO:0001846) |
1.1 | 6.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.1 | 6.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.1 | 4.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.1 | 6.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.1 | 66.3 | GO:0051020 | GTPase binding(GO:0051020) |
1.1 | 4.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.0 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
1.0 | 1.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.0 | 1.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
1.0 | 21.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.0 | 3.1 | GO:0048185 | activin binding(GO:0048185) |
1.0 | 4.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.0 | 24.5 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
1.0 | 3.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.0 | 3.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 23.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 25.1 | GO:0015485 | cholesterol binding(GO:0015485) |
1.0 | 3.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.0 | 5.0 | GO:0050733 | RS domain binding(GO:0050733) |
1.0 | 5.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.0 | 2.0 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
1.0 | 2.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.0 | 176.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.0 | 1.0 | GO:0004096 | catalase activity(GO:0004096) |
1.0 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.0 | 6.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.0 | 2.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.0 | 1.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 4.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.0 | 2.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.0 | 4.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.0 | 8.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 15.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.9 | 2.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 20.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.9 | 24.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.9 | 81.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.9 | 9.3 | GO:0070990 | snRNP binding(GO:0070990) |
0.9 | 6.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.9 | 2.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.9 | 18.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.9 | 5.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.9 | 2.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.9 | 7.3 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.9 | 3.6 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.9 | 2.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.9 | 6.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.9 | 11.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.9 | 1.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.9 | 5.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.9 | 2.7 | GO:0016595 | glutamate binding(GO:0016595) |
0.9 | 1.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.9 | 2.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.9 | 1.8 | GO:0002046 | opsin binding(GO:0002046) |
0.9 | 1.8 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.9 | 20.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.9 | 7.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.9 | 8.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.9 | 18.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.9 | 4.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.9 | 18.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.9 | 4.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.9 | 21.4 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.9 | 30.8 | GO:0060090 | binding, bridging(GO:0060090) |
0.9 | 2.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.9 | 8.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.9 | 453.7 | GO:0000975 | regulatory region DNA binding(GO:0000975) |
0.9 | 6.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.9 | 24.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.8 | 3.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 5.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.8 | 4.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.8 | 3.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.8 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.8 | 2.5 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.8 | 5.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.8 | 4.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.8 | 130.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.8 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.8 | 2.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 15.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.8 | 12.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.8 | 0.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.8 | 6.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.8 | 1.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.8 | 4.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.8 | 3.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.8 | 1.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.8 | 2.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.8 | 4.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.8 | 10.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.8 | 4.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.8 | 15.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.8 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.8 | 7.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.8 | 0.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.8 | 2.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 1.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.8 | 1.5 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.8 | 2.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 1.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.8 | 107.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.8 | 0.8 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.8 | 3.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 5.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 2.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.8 | 3.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.7 | 0.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.7 | 2.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.7 | 10.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.7 | 3.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.7 | 3.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.7 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 0.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.7 | 2.2 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.7 | 14.7 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.7 | 2.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.7 | 40.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.7 | 1.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.7 | 1.5 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.7 | 4.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.7 | 1.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.7 | 1.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 12.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.7 | 1.4 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.7 | 37.1 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 1.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.7 | 4.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.7 | 1.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.7 | 14.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.7 | 3.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.7 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 6.9 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.7 | 6.2 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 42.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.7 | 2.7 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 2.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 5.4 | GO:0043531 | ADP binding(GO:0043531) |
0.7 | 2.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.7 | 2.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.7 | 1.3 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.7 | 2.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.7 | 4.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 17.2 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.7 | 2.6 | GO:0001848 | complement binding(GO:0001848) |
0.7 | 2.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.7 | 0.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.7 | 3.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.7 | 3.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.7 | 4.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.6 | 5.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 5.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.6 | 0.6 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.6 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.6 | 34.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.6 | 29.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.6 | 3.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 1.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 160.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.6 | 4.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 18.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 6.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 4.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.6 | 0.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.6 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 2.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 10.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.6 | 1.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.6 | 13.7 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.6 | 2.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 1.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.6 | 3.5 | GO:0016160 | amylase activity(GO:0016160) |
0.6 | 5.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 2.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.6 | 0.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.6 | 4.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.6 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.6 | 0.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) ammonia-lyase activity(GO:0016841) |
0.6 | 2.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 1.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.6 | 0.6 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.6 | 0.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 1.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 5.1 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.6 | 4.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 16.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.6 | 3.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.6 | 4.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 6.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.5 | 37.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.5 | 24.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.5 | 3.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 355.9 | GO:0003677 | DNA binding(GO:0003677) |
0.5 | 2.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.5 | 21.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 2.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.5 | 3.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 1.1 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.5 | 1.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.5 | 2.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 4.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 3.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 13.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 1.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.5 | 23.6 | GO:0004519 | endonuclease activity(GO:0004519) |
0.5 | 4.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.5 | 9.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.5 | 0.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 24.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 3.9 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.5 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 1.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 186.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.5 | 2.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.5 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 2.4 | GO:0004386 | helicase activity(GO:0004386) |
0.5 | 93.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.5 | 4.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 0.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.5 | 1.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.4 | 10.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 2.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 1.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 2.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 3.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.4 | 28.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.4 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 6.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 36.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.4 | 2.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 0.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.4 | 0.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 5.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 1.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 5.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 0.8 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.4 | 22.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.4 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 9.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.4 | 1.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 2.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 6.4 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 0.3 | GO:0070696 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.3 | 1.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 2.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 37.5 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 42.5 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.3 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 5.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 2.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.3 | 5.7 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.3 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.8 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.3 | 1.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.3 | 9.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 4.4 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.3 | 1.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 1.1 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 0.8 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 0.3 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.3 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 14.2 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.3 | 28.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.3 | 9.9 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.3 | 23.7 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 5.0 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 7.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.2 | 0.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 1.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 3.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 6.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.2 | 2.3 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 7.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleoside:sodium symporter activity(GO:0005415) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 1.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 4.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 7.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 15.2 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.2 | 14.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.6 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.7 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 4.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 11.5 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 2.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.2 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 0.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 82.7 | GO:0046872 | metal ion binding(GO:0046872) |
0.1 | 0.2 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 3.4 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.1 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 6.5 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0047555 | cGMP binding(GO:0030553) 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 42.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 2.5 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 7.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
5.2 | 51.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
5.1 | 5.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
4.8 | 43.1 | ST STAT3 PATHWAY | STAT3 Pathway |
4.6 | 203.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
4.3 | 136.2 | PID ARF6 PATHWAY | Arf6 signaling events |
3.9 | 93.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
3.2 | 35.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
3.1 | 27.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
3.0 | 57.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
2.9 | 55.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
2.9 | 126.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
2.9 | 2.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
2.8 | 42.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.8 | 73.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.8 | 2.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
2.7 | 5.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.7 | 37.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.6 | 47.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.6 | 17.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.6 | 33.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
2.5 | 12.6 | PID IGF1 PATHWAY | IGF1 pathway |
2.5 | 109.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
2.5 | 47.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
2.4 | 28.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
2.4 | 18.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.3 | 20.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.3 | 34.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
2.2 | 13.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.2 | 11.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.2 | 10.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.1 | 102.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
2.1 | 14.6 | PID ALK1 PATHWAY | ALK1 signaling events |
2.1 | 43.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.1 | 78.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
2.0 | 24.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.0 | 24.2 | ST GAQ PATHWAY | G alpha q Pathway |
2.0 | 30.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.0 | 6.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.9 | 97.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.9 | 36.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.9 | 34.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.9 | 91.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.9 | 24.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.8 | 44.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.8 | 26.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.8 | 5.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.7 | 12.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.7 | 10.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.7 | 30.3 | PID RAS PATHWAY | Regulation of Ras family activation |
1.7 | 15.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.7 | 13.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.7 | 5.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.7 | 19.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.7 | 11.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.7 | 58.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.7 | 14.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.6 | 14.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.6 | 9.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.6 | 16.2 | PID RHOA PATHWAY | RhoA signaling pathway |
1.6 | 50.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.6 | 37.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
1.6 | 6.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.6 | 53.8 | PID P73PATHWAY | p73 transcription factor network |
1.6 | 42.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.6 | 21.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.6 | 10.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.6 | 35.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.5 | 18.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.5 | 4.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.5 | 51.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.4 | 21.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.4 | 14.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.4 | 11.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.4 | 26.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.4 | 73.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.4 | 9.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.3 | 16.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.3 | 18.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.3 | 31.2 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 169.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.3 | 6.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.2 | 14.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.2 | 8.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.2 | 10.7 | PID ALK2 PATHWAY | ALK2 signaling events |
1.2 | 10.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.2 | 3.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.1 | 7.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.1 | 5.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.1 | 18.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.1 | 1.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.1 | 54.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.1 | 4.3 | PID EPO PATHWAY | EPO signaling pathway |
1.1 | 6.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.1 | 5.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.1 | 11.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.0 | 5.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.0 | 9.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.0 | 13.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
1.0 | 5.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.0 | 22.4 | PID E2F PATHWAY | E2F transcription factor network |
1.0 | 10.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.0 | 13.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.0 | 17.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.9 | 11.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.9 | 1.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.9 | 4.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.9 | 18.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.9 | 15.3 | PID FGF PATHWAY | FGF signaling pathway |
0.9 | 16.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.9 | 6.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.9 | 13.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 29.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.9 | 10.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.8 | 13.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.8 | 2.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 9.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.8 | 10.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.8 | 4.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.8 | 28.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.8 | 15.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.8 | 9.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 11.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 3.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 3.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.7 | 2.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.7 | 1.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 12.3 | PID ATR PATHWAY | ATR signaling pathway |
0.6 | 6.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 5.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 1.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 1.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.6 | 8.4 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 2.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 108.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.5 | 2.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 3.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 5.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 3.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 2.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 8.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 4.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 3.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 4.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 9.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 6.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 1.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 4.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 4.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 4.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 14.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 17.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 75.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
6.3 | 63.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
6.0 | 17.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
5.4 | 150.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
4.7 | 47.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
4.6 | 59.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
4.6 | 73.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
4.4 | 35.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
4.3 | 43.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
4.2 | 4.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
4.1 | 12.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
4.1 | 4.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
3.9 | 39.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.9 | 42.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
3.8 | 34.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
3.8 | 67.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
3.6 | 36.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
3.6 | 35.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
3.5 | 80.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
3.4 | 61.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
3.4 | 13.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.2 | 3.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
3.1 | 3.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
3.1 | 59.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
3.1 | 21.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
3.1 | 15.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.0 | 45.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
3.0 | 3.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
2.9 | 38.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
2.9 | 29.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
2.9 | 22.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.9 | 11.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
2.9 | 42.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.9 | 128.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.8 | 25.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.8 | 13.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
2.8 | 30.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.7 | 27.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.7 | 5.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
2.7 | 37.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.7 | 24.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
2.7 | 45.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.6 | 79.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.6 | 47.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
2.6 | 15.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.6 | 15.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
2.6 | 35.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.5 | 19.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.4 | 33.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
2.4 | 26.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.4 | 52.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.4 | 33.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
2.4 | 33.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.4 | 40.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.4 | 9.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
2.4 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.4 | 11.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
2.3 | 62.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.3 | 13.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
2.3 | 9.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
2.3 | 100.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.3 | 29.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.3 | 31.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.2 | 17.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.2 | 8.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
2.2 | 26.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.2 | 17.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.2 | 48.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
2.2 | 6.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.2 | 95.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
2.2 | 47.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.1 | 19.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
2.1 | 2.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
2.1 | 36.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.1 | 19.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.1 | 157.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.1 | 53.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
2.0 | 24.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.0 | 16.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.0 | 2.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
2.0 | 38.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.9 | 17.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.9 | 110.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.9 | 25.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.9 | 9.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.9 | 3.8 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
1.9 | 11.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.8 | 3.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.8 | 28.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.8 | 12.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.8 | 17.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.8 | 17.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.8 | 36.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.7 | 37.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.7 | 37.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.7 | 8.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.7 | 8.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.7 | 3.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.7 | 5.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.7 | 49.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.7 | 3.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.6 | 29.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.6 | 35.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.6 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.6 | 16.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.6 | 19.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.6 | 11.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.6 | 10.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.6 | 14.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.5 | 35.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.5 | 18.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.5 | 3.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.5 | 9.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.5 | 3.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.5 | 20.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.5 | 5.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.5 | 7.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.5 | 4.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.5 | 69.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.4 | 20.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.4 | 31.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
1.4 | 41.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.4 | 9.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.4 | 17.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
1.4 | 8.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.4 | 1.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.4 | 12.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.4 | 9.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.4 | 172.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.4 | 6.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.4 | 17.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.4 | 5.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.3 | 6.7 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
1.3 | 10.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.3 | 40.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.3 | 26.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.3 | 24.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.3 | 17.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.2 | 13.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.2 | 8.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.2 | 1.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.2 | 13.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.2 | 20.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.2 | 45.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.2 | 24.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.2 | 20.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.1 | 3.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.1 | 22.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.1 | 20.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
1.1 | 5.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.1 | 45.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
1.1 | 18.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
1.1 | 11.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.1 | 14.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.1 | 5.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.1 | 8.8 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
1.1 | 8.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.1 | 5.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.1 | 49.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.1 | 18.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.1 | 24.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.1 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.0 | 9.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.0 | 12.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
1.0 | 61.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.0 | 8.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.0 | 4.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 10.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.0 | 3.0 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.0 | 14.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.0 | 2.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.0 | 84.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
1.0 | 10.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.0 | 1.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.0 | 1.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.9 | 7.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.9 | 10.3 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.9 | 88.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.9 | 14.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.9 | 11.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.9 | 1.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.9 | 6.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.9 | 8.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.9 | 35.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.9 | 99.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.9 | 19.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.9 | 14.7 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.9 | 2.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.9 | 16.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.9 | 10.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.9 | 23.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.9 | 7.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.8 | 12.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.8 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 31.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.8 | 4.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.8 | 26.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 2.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.8 | 6.2 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.8 | 25.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.7 | 1.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.7 | 6.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.7 | 23.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.7 | 7.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.7 | 9.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.7 | 2.1 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.7 | 3.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.7 | 15.9 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.7 | 7.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 6.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 10.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.7 | 2.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.7 | 2.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.6 | 3.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.6 | 3.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 14.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 16.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 3.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.6 | 32.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 10.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 2.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.6 | 9.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.6 | 3.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 2.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 10.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 6.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.6 | 0.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.6 | 8.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.5 | 1.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 3.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 4.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 6.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.5 | 5.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 1.5 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.5 | 5.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 6.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 1.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.5 | 3.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.5 | 7.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 11.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 2.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 6.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.4 | 2.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 25.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 0.8 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 5.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 2.6 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.4 | 4.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 2.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 1.4 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.3 | 4.5 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.3 | 0.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 7.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.2 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 2.9 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.2 | 3.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 0.5 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 2.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 0.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 1.9 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 18.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 2.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.2 | 4.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 1.3 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 5.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.0 | 0.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |